UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | Y | Z
Number of items: 645.

A

ARESU, M; Brage, S; Mindell, J; (2009) Physical fitness in adults. (Health Survey for England (2008). Volume 1 Physical activity and fitness ). The Health and Social care Information Centre: Leeds.

Agarwal, A; Kocjan, G; (2009) FNAC Thyroid Reporting Categories: Value of Using the British Thyroid Association (Thy 1 to Thy 5) Thyroid FNAC Reporting Guidelines. CYTOPATHOLOGY , 20 (2) 133 - 134. 10.1111/j.1365-2303.2008.00625.x.

Ahlskog, JKJ; Schliemann, C; Marlind, J; Qureshi, U; Ammar, A; Pedley, RB; Neri, D; (2009) Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours. BRIT J CANCER , 101 (4) 645 - 657. 10.1038/sj.bjc.6605200.

Ahmed, N; Salsman, VS; Yvon, E; Louis, CU; Perlaky, L; Wels, WS; Dishop, MK; (2009) Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression. MOLECULAR THERAPY , 17 (10) pp. 1779-1787. 10.1038/mt.2009.133.

Al-Qassab, H; Smith, MA; Irvine, EE; Guillermet-Guibert, J; Claret, M; Choudhury, AI; Selman, C; (2009) Dominant Role of the p110 beta Isoform of PI3K over p110 alpha in Energy Homeostasis Regulation by POMC and AgRP Neurons. CELL METAB , 10 (5) 343 - 354. 10.1016/j.cmet.2009.09.008. Gold open access

Altvater, B; Landmeier, S; Pscherer, S; Temme, J; Schweer, K; Kailayangiri, S; Campana, D; (2009) 2B4 (CD244) Signaling by Recombinant Antigen-specific Chimeric Receptors Costimulates Natural Killer Cell Activation to Leukemia and Neuroblastoma Cells. CLINICAL CANCER RESEARCH , 15 (15) pp. 4857-4866. 10.1158/1078-0432.CCR-08-2810.

Amit, I; Garber, M; Chevrier, N; Leite, AP; Donner, Y; Eisenhaure, T; Guttman, M; (2009) Unbiased Reconstruction of a Mammalian Transcriptional Network Mediating Pathogen Responses. Science , 326 (5950) pp. 257-263. 10.1126/science.1179050.

An, S; Henriquez, N; Puls, F; Brandner, S; (2009) Oligodendrogliomas: relation of morphology to 1p/19q genotype. In: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. (pp. 11 - 12). BLACKWELL PUBLISHING

André, T; Boni, C; Navarro, M; Tabernero, J; Hickish, T; Topham, C; Bonetti, A; (2009) Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol , 27 (19) pp. 3109-3116. 10.1200/JCO.2008.20.6771.

Apostolidou, S; Hadwin, R; Burnell, M; Jones, A; Baff, D; Pyndiah, N; Mould, T; (2009) DNA methylation analysis in liquid-based cytology for cervical cancer screening. INT J CANCER , 125 (12) 2995 - 3002. 10.1002/ijc.24745.

Arce, F; Rowe, HM; Chain, B; Lopes, L; Collins, MK; (2009) Lentiviral Vectors Transduce Proliferating Dendritic Cell Precursors Leading to Persistent Antigen Presentation and Immunization. MOL THER , 17 (9) 1643 - 1650. 10.1038/mt.2009.149.

Arkenau, ; (2009) Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: A pooled analysis of randomized trials (Journal of Clinical Oncology (2008) 26 (5910-5917)). Journal of Clinical Oncology , 27 (34) p. 5859.

Arkenau, H; Evans, J; Lokelma, M; Roxburgh, P; Morisson, R; Coffey, M; Gill, G; (2009) A phase I study of the combination of intravenous Reolysin (REO) and gemcitabine (GEM) in patients (pts) with advanced cancer. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. ? - ?). AMER SOC CLINICAL ONCOLOGY

Arkenau, H-T; (2009) Gastric cancer in the era of molecularly targeted agents: current drug development strategies. J Cancer Res Clin Oncol , 135 (7) pp. 855-866. 10.1007/s00432-009-0583-7.

Arkenau, H-T; Barriuso, J; Olmos, D; Ang, JE; de Bono, J; Judson, I; Kaye, S; (2009) Prospective validation of a prognostic score to improve patient selection for oncology phase I trials. J Clin Oncol , 27 (16) pp. 2692-2696. 10.1200/JCO.2008.19.5081.

Arkenau, H-T; Brunetto, AT; Barriuso, J; Olmos, D; Eaton, D; de Bono, J; Judson, I; (2009) Clinical benefit of new targeted agents in phase I trials in patients with advanced colorectal cancer. Oncology , 76 (3) pp. 151-156. 10.1159/000195884.

Arkenau, HT; (2009) Capecitabine/oxaliplatin results in outcome similar to infusional 5 FU/leucovorin/oxaliplatin in MCRC: Results of a meta-analysis. American Journal of Hematology/ Oncology , 8 (5)

Averdam, A; Petersen, B; Beck, S; Reinhardt, R; Walter, L; (2009) A novel system of polymorphic NK cell receptors identified in primates. In: TISSUE ANTIGENS. (pp. 386 - 386). WILEY-BLACKWELL PUBLISHING, INC

Averdam, A; Petersen, B; Rosner, C; Neff, J; Roos, C; Eberle, M; Aujard, F; (2009) A Novel System of Polymorphic and Diverse NK Cell Receptors in Primates. PLOS GENET , 5 (10) , Article e1000688. 10.1371/journal.pgen.1000688. Green open access
file

Ayaru, L; Stoeber, K; Webster, GJ; Hatfield, ARW; Wollenschlaeger, A; Williams, G; Pereira, SP; (2009) DIAGNOSIS OF PANCREATICOBILIARY MALIGNANCY BY DETECTION OF MINICHROMOSOME MAINTENANCE PROTEIN 5 IN BILIARY BRUSH CYTOLOGY SPECIMENS. In: GUT. (pp. A25 - A25). B M J PUBLISHING GROUP

B

BBC, NO; (2009) Thalidomide lung cancer 'failure'. UNSPECIFIED

Backdahl, L; Bushell, A; Beck, S; (2009) Inflammatory signalling as mediator of epigenetic modulation in tissue-specific chronic inflammation. INT J BIOCHEM CELL B , 41 (1) 176 - 184. 10.1016/j.biocel.2008.08.023.

Backdahl, L; Herberth, M; Wilson, G; Tate, P; Campos, LS; Cortese, R; Eckhardt, F; (2009) Gene body methylation of the dimethylarginine dimethylamino-hydrolase 2 (Ddah2) gene is an epigenetic biomarker for neural stem cell differentiation. EPIGENETICS , 4 (4) 248 - 254.

Backdahl, L; Herberth, M; Wilson, G; Tate, P; Campos, LS; Cortese, R; Eckhardt, F; (2009) Gene body methylation of the dimethylarginine dimethylamino-hydrolase 2 (Ddah2) gene is an epigenetic biomarker for neural stem cell differentiation. Epigenetics , 4 (4) pp. 248-254.

Bajwa, A; Blunt, N; Vyas, S; Suliman, I; Bridgewater, J; Hochhauser, D; Ledermann, JA; (2009) Primary tumour resection and survival in the palliative management of metastatic colorectal cancer. EJSO , 35 (2) 164 - 167. 10.1016/j.ejso.2008.06.005.

Balasubramaniam, T; Johnson, R; Cwynarski, K; Ackroyd, S; El-Sharkawi, D; Ashcroft, J; McNamara, C; (2009) Treatment outcomes of primary CNS lymphoma with IDARAM chemotherapy regime. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 14 - 14). WILEY-BLACKWELL PUBLISHING, INC

Balbi, KJ; Rocha, EPC; Feil, EJ; (2009) The temporal dynamics of slightly deleterious mutations in Escherichia coli and Shigella spp. Mol Biol Evol , 26 (2) pp. 345-355. 10.1093/molbev/msn252.

Banerjee, L; Mansour, M; Khwaja, A; (2009) Combined blockade of PI3-kinase and mTOR synergizes with gamma-secretase inhibitors to induce a high level of cell death in T-cell acute lymphoblastic leukaemia cells with activated Notch signalling. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 9 - 10). WILEY-BLACKWELL PUBLISHING, INC

Baou, M; Jewell, A; Muthurania, A; Wickremasinghe, RG; Yong, KL; Carr, R; Marsh, P; (2009) Involvement of Tis11b, an AU-rich binding protein, in induction of apoptosis by rituximab in B cell chronic lymphocytic leukemia cells. LEUKEMIA , 23 (5) 986 - 989. 10.1038/leu.2008.340.

Barrowcliffe, TW; Chandler, WL; Favaloro, EJ; Gardiner, C; Goodeve, A; Gray, E; Jennings, I; (2009) Dorothy M. Adcock MD. In: UNSPECIFIED John Wiley & Sons

Bartlett, JMS; Campbell, FM; Ibrahim, M; Thomas, J; Wenyck, I; Ellis, IO; Kay, E; (2009) A UK NEQAS ring study evaluating observer variation in the diagnosis of HER2 amplification using the Kreatech (TM) HER2 FISH probe. In: CANCER RESEARCH. (pp. 206S - 206S). AMER ASSOC CANCER RESEARCH

Bartlett, JMS; Campbell, FM; Ibrahim, M; Wencyk, P; Ellis, I; Kay, E; Connolly, Y; (2009) Chromogenic In Situ Hybridization A Multicenter Study Comparing Silver In Situ Hybridization With FISH. AM J CLIN PATHOL , 132 (4) 514 - 520. 10.1309/AJCPXY3MJ6GSRCYP.

Bartlett, JMS; Miller, K; (2009) HER2: Closing the Gap Between Laboratory Testing and Clinical Practice Reply. AM J CLIN PATHOL , 131 (6) 898 - 899.

Baxter-Lowe, LA; Maiers, M; Spellman, SR; Haagenson, MD; Wang, T; Fernandez-Vina, M; Marsh, SGE; (2009) HLA-A Disparities Illustrate Challenges for Ranking the Impact of HLA Mismatches on Bone Marrow Transplant Outcomes in the United States. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION , 15 (8) pp. 971-981. 10.1016/j.bbmt.2009.04.015.

Baxter-Lowe, LA; Maiers, M; Spellman, SR; Haagenson, MD; Wang, T; Fernandez-Vina, M; Marsh, SGE; (2009) HLA-A disparities illustrate challenges for ranking the impact of HLA mismatches on bone marrow transplant outcomes in the United States. pp. 971-981.

Bazeos, A; Marin, D; Gerrard, G; Szydlo, R; Milojkovic, D; Reid, A; de Lavallade, H; (2009) BCR-ABL1 Oncogene Down-regulates the Expression of OCT1 in CML. In: (Proceedings) 51st Annual Meeting of the American-Society-of-Hematology. (pp. p. 1258). AMER SOC HEMATOLOGY

Beck, S; (2009) Reverse Phenotyping: Towards an integrated (epi)genomic approach to complex phenotypes and common disease. In: JOURNAL OF MEDICAL GENETICS. (pp. S31 - S31). B M J PUBLISHING GROUP

Behjati, S; Bamfo, JEAK; Bates, AW; Veerareddy, S; (2009) A near miss: Lessons from a case of omental pregnancy. J OBSTET GYNAECOL , 29 (6) 559 - 560. 10.1080/01443610902984946.

Behjati, S; Zilbauer, M; Heuschkel, R; Phillips, A; Salvestrini, C; Torrente, F; Bates, AW; (2009) Defining Eosinophilic Colitis in Children: Insights From a Retrospective Case Series. J PEDIATR GASTR NUTR , 49 (2) 208 - 215.

Bell, CG; Beck, S; (2009) Advances in the identification and analysis of allele-specific expression. GENOME MEDICINE , 1 (ARTN 56) 10.1186/gm56.

Bell, CG; Wood, DR; Cheong, SJH; Kwan, E; Sinosich, M; Delprado, W; Baumgart, KW; (2009) Molecular confirmation of pathological specimen integrity in Australasia. Pathology , 41 (3) pp. 280-283. 10.1080/00313020902756311.

Bellodi, C; Lidonnici, MR; Hamilton, A; Helgason, GV; Soliera, AR; Ronchetti, M; Galavotti, S; (2009) Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J CLIN INVEST , 119 (5) 1109 - 1123. 10.1172/JCI35660.

Bendall, SC; Hughes, C; Campbell, JL; Stewart, MH; Pittock, P; Liu, S; Bonneil, E; (2009) An Enhanced Mass Spectrometry Approach Reveals Human Embryonic Stem Cell Growth Factors in Culture. MOLECULAR & CELLULAR PROTEOMICS , 8 (3) pp. 421-432. 10.1074/mcp.M800190-MCP200.

Berenjeno, IM; Vanhaesebroeck, B; (2009) PI3K regulatory subunits lose control in cancer. Cancer Cell , 16 (6) pp. 449-450. 10.1016/j.ccr.2009.11.017.

Bergamini, G; Cigana, C; Sorio, C; Della Peruta, M; Pompella, A; Corti, A; Huaux, FA; (2009) Effects of Azithromycin on Glutathione S-Transferases in Cystic Fibrosis Airway Cells. AM J RESP CELL MOL , 41 (2) 199 - 206. 10.1165/rcmb.2008-0013OC.

Berro, M; Mayor, NP; Cooke, L; Kusminsky, G; Marsh, SGE; Madrigal, JA; Shaw, BE; (2009) TGFB1 codon 10 polymorphism: Impact on outcome in allogeneic unrelated donor hematopoietic stem cell transplantation. In: TISSUE ANTIGENS. (pp. 488 - 488). WILEY-BLACKWELL PUBLISHING, INC

Bhosle, J; Makris, A; Hartley, J; Hochhauser, D; (2009) Modulation of topoisomerase II\#945; poison induced DNA damage and repair by tyrosine kinase inhibitiors. CANCER RESEARCH , 69

Bhosle, J; Makris, A; Hartley, JA; Hochhauser, D; (2009) Effect of chronic exposure to tyrosine kinase inhibitors on chemotherapy-induced DNA damage in the SKBR3 breast cancer cell line. In: CANCER RESEARCH. (pp. 117S - 117S). AMER ASSOC CANCER RESEARCH

Billottet, C; Banerjee, L; Vanhaesebroeck, B; Khwaja, A; (2009) Inhibition of Class I Phosphoinositide 3-Kinase Activity Impairs Proliferation and Triggers Apoptosis in Acute Promyelocytic Leukemia without Affecting Atra-Induced Differentiation. CANCER RES , 69 (3) 1027 - 1036. 10.1158/0008-5472.CAN-08-2608.

Black, E; Glasspool, DW; Grando, MA; Patkar, V; Fox, J; (2009) Goal-Based Decisions for Dynamic Planning. In: Combi, C and Shahar, Y and AbuHanna, A, (eds.) ARTIFICIAL INTELLIGENCE IN MEDICINE, PROCEEDINGS. (pp. 96 - 100). SPRINGER-VERLAG BERLIN

Boffa, MC; Cohen, H; Tincani, A; (2009) Diagnostic criteria for the obstetric antiphospholipid syndrome. In: (Proceedings) VII European Forum on antiphospholipid antibodies.

Boone, JJM; Bhosle, J; Tilby, MJ; Hartley, JA; Hochhauser, D; (2009) Involvement of the HER2 pathway in repair of DNA damage produced by chemotherapeutic agents. MOL CANCER THER , 8 (11) 3015 - 3023. 10.1158/1535-7163.MCT-09-0219.

Boshoff, C; Posner, M; (2009) Targeting EGFR in head and neck cancer: a decade of progress. NAT CLIN PRACT ONCOL , 6 (3) 123 - 123. 10.1038/ncponc1328.

Bowen, D; Groves, MJ; Burnett, AK; Patel, Y; Allen, C; Green, C; Gale, RE; (2009) TP53 gene mutation is frequent in patients with acute myeloid leukemia and complex karyotype, and is associated with very poor prognosis. LEUKEMIA , 23 (1) 203 - 206. 10.1038/leu.2008.173.

Bowers, SR; Mirabella, F; Calero-Nieto, FJ; Valeaux, S; Hadjur, S; Baxter, EW; Merkenschlager, M; (2009) A Conserved Insulator That Recruits CTCF and Cohesin Exists between the Closely Related but Divergently Regulated Interleukin-3 and Granulocyte-Macrophage Colony-Stimulating Factor Genes. MOL CELL BIOL , 29 (7) 1682 - 1693. 10.1128/MCB.01411-08.

Brewin, J; Mancao, C; Straathof, K; Karlsson, H; Samarasinghe, S; Amrolia, PJ; Pule, M; (2009) Generation of EBV-specific cytotoxic T cells that are resistant to calcineurin inhibitors for the treatment of posttransplantation lymphoproliferative disease. BLOOD , 114 (23) pp. 4792-4803. 10.1182/blood-2009-07-228387.

Bridgewater, J; Valle, J; Palmer, D; Cunningham, D; Anthoney, D; Maraveyas, A; Hughes, S; (2009) Gemcitabine with or without cisplatin in patients (pts) with advanced or metastatic biliary tract cancer (ABC): final results of the UK ABC-02 trial. In: EJC SUPPLEMENTS. (pp. 361 - 361). PERGAMON-ELSEVIER SCIENCE LTD

Brown, ACN; Hallouane, D; Mawby, WJ; Karet, FE; Saleem, MA; Howie, AJ; Toye, AM; (2009) RhCG is the major putative ammonia transporter expressed in the human kidney, and RhBG is not expressed at detectable levels. Am J Physiol Renal Physiol , 296 (6) F1279-F1290. 10.1152/ajprenal.00013.2009.

Brown, NW; Hiwarkar, P; Shaw, BE; Kulkarni, S; Saso, R; Evans, S; Treleaven, J; (2009) Mycophenolic Acid Concentration Monitoring for Mycophenolate Mofetil-treated Graft versus Host Disease. In: THERAPEUTIC DRUG MONITORING. (pp. 663 - 663). LIPPINCOTT WILLIAMS & WILKINS

Bruce, AW; Lopez-Contreras, AJ; Flicek, P; Down, TA; Dhami, P; Dillon, SC; Koch, CM; (2009) Functional diversity for REST (NRSF) is defined by in vivo binding affinity hierarchies at the DNA sequence level. GENOME RES , 19 (6) 994 - 1005. 10.1101/gr.089086.108.

Brunelli, M; Manfrin, E; Martignoni, G; Miller, K; Remo, A; Reghellin, D; Bersani, S; (2009) Genotypic Intratumoral Heterogeneity in Breast Carcinoma With HER2/neu Amplification. AM J CLIN PATHOL , 131 (5) 678 - 682. 10.1309/AJCP09VUTZWZXBMJ.

Bruno, L; Mazzarella, L; Hoogenkamp, M; Hertweck, A; Cobb, BS; Sauer, S; Hadjur, S; (2009) Runx proteins regulate Foxp3 expression. J EXP MED , 206 (11) 2329 - 2337. 10.1084/jem.20090226.

Bucciarelli-Ducci, C; Lyne, J; Reyes, E; Assomull, R; Petryka, J; Watkins, S; Gatehouse, P; (2009) Diagnostic Performance of Perfusion Cardiovascular Magnetic Resonance Compared With Gated Myocardial Perfusion SPECT in Patients With Known or Suspected Coronary Artery Disease. In: CIRCULATION. (pp. S1094 - S1094). LIPPINCOTT WILLIAMS & WILKINS

C

CRT, ; Stoeber, K; Williams, GH; (2009) Diagnostic, predictive and prognostic testing for cancer. WO/2009/050461.

Calvaruso, V; Burroughs, AK; Standish, R; Manousou, P; Grillo, F; Leandro, G; Maimone, S; (2009) Computer-Assisted Image Analysis of Liver Collagen: Relationship to Ishak Scoring and Hepatic Venous Pressure Gradient. HEPATOLOGY , 49 (4) 1236 - 1244. 10.1002/hep.22745.

Cantu, C; Ierardi, R; Fugazza, C; Grande, V; Alborelli, I; Ottolenghi, S; Ferrari, G; (2009) SOX6 OVEREXPRESSION IN HUMAN ERYTHROID PROGENITORS STRONGLY ENHANCES THEIR TERMINAL MATURATION. In: (Proceedings) 38th Annual Scientific Meeting of the ISEH-Society-for-Hematology-and-Stem-Cells. (pp. S12-S12). ELSEVIER SCIENCE INC

Cappellini, MD; Perrotta, S; Agaoglu, L; Aydinok, Y; Capra, M; Canatan, D; Drelichman, G; (2009) Efficacy and Safety of Deferasirox (Exjade (R)) in Patients with beta-Thalassemia Major Treated for up to 5 Years. In: BLOOD. (pp. 1558 - 1559). AMER SOC HEMATOLOGY

Carle, D; Bielack, S; Sydes, M; Butterfass-Bahloul, T; Calaminus, G; Jovic, G; Marina, N; (2009) The European and American Osteosarcoma Study Group protocol EURAMOS 1: Successful transatlantic cooperation in osteosarcoma. In:

Carpenter, JP; Alpendurada, F; Deac, M; Kirk, P; Porter, JB; Walker, JM; Banya, W; (2009) Impact of Myocardial Iron Loading On Right Ventricular Function. In: BLOOD. (pp. 794 - 794). AMER SOC HEMATOLOGY

Cave, J; Edwards, SG; Miller, RF; Ardeshna, KM; Lee, SM; (2009) Should we implement 'opt-out' HIV testing for patients with lymphoma? CLIN MED , 9 (4) 320 - 322.

Chacko, S; Taskapan, H; Roscoe, J; Stein, J; Woods, E; Denton, T; Ting, R; (2009) Treatment of hyper-IgG4 disease with sequential corticosteroids and tamoxifen - case report and review of the literature. Clin Nephrol , 72 (5) pp. 414-417.

Chaffe, B; Jones, J; Milkins, C; Taylor, C; Asher, D; Glencross, H; Murphy, M; (2009) UK transfusion laboratory collaborative: recommended minimum standards for hospital transfusion laboratories. Transfusion medicine , 19 pp. 156-158.

Chan, CF; Gatehouse, PD; Hughes, R; Roughton, M; Pennell, DJ; Firmin, DN; (2009) Novel Technique Used to Detect Swallowing in Volume-Selective Turbo Spin-Echo (TSE) for Carotid Artery Wall Imaging. J MAGN RESON IMAGING , 29 (1) 211 - 216. 10.1002/jmri.21607.

Chanalaris, A; Grace, C; Gale, R; Linch, D; Nacheva, EP; (2009) GENOME PROFILING OF NORMAL KARYOTYPE AML WITH HIGH DENSITY ARRAY COMPARATIVE GENOME HYBRIDISATION. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 114 - 114). FERRATA STORTI FOUNDATION Gold open access

Chapgier, A; Kong, X-F; Boisson-Dupuis, S; Jouanguy, E; Averbuch, D; Feinberg, J; Zhang, S-Y; (2009) A partial form of recessive STAT1 deficiency in humans. J Clin Invest , 119 (6) pp. 1502-1514. 10.1172/JCI37083.

Chapman, CE; Stainsby, D; Jones, H; Love, E; Massey, E; Win, N; Navarrete, C; (2009) Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion , 49 (3) pp. 440-452. 10.1111/j.1537-2995.2008.01948.x.

Charolidi, N; Cynthia, LA; Signore, M; Richard, GJ; Martinez-Barbera, JP; (2009) Developmental regulatory targets of the homeobox transcription factor HESX1. Mechanisms of Development , 126 (Supple) S117 - S117. 10.1016/j.mod.2009.06.220. Green open access
file

Cheng, YY; Siddle, HV; Beck, S; Eldridge, MDB; Belov, K; (2009) High levels of genetic variation at MHC class II DBB loci in the tammar wallaby (Macropus eugenii). IMMUNOGENETICS , 61 (2) 111 - 118. 10.1007/s00251-008-0347-6.

Cheng, YY; Wakefield, M; Siddle, HV; Coggill, PC; Herbert, CA; Beck, S; Belov, K; (2009) Isolation and characterization of 10 MHC Class I-associated microsatellite loci in tammar wallaby (Macropus eugenii). MOL ECOL RESOUR , 9 (1) 346 - 349. 10.1111/j.1755-0998.2008.02401.x.

Cheung, CW; Khwaja, A; (2009) Stromal cell-mediated drug resistance in acute myeloid leukaemia (AML) is attenuated by PI103, a dual inhibitor of Class I PI3-Kinase (PI3K) and mTOR. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 2 - 2). WILEY-BLACKWELL PUBLISHING, INC

Chew, SK; Chen, P; Link, N; Galindo, KA; Pogue, K; Abrams, JM; (2009) Genome-wide silencing in Drosophila captures conserved apoptotic effectors. Nature , 460 (7251) pp. 123-127. 10.1038/nature08087.

Chickarmane, V; Enver, T; Peterson, C; (2009) Computational Modeling of the Hematopoietic Erythroid-Myeloid Switch Reveals Insights into Cooperativity, Priming, and Irreversibility. PLOS COMPUT BIOL , 5 (1) , Article e1000268. 10.1371/journal.pcbi.1000268. Green open access
file

Chua, MLK; Kamis, HB; Loong, SL; (2009) In vitro interaction of cyclooxygenase-2 (COX-2) inhibitors with radiation in nasopharyngeal carcinoma: dependent on sequence of administration. In: ORAL ONCOLOGY. (pp. 236 - 236). ELSEVIER SCIENCE BV

Chua, MLK; Ong, SC; Wee, JTS; Ng, DCE; Gao, F; Tan, TWK; Fong, KW; (2009) COMPARISON OF 4 MODALITIES FOR DISTANT METASTASIS STAGING IN ENDEMIC NASOPHARYNGEAL CARCINOMA. HEAD NECK-J SCI SPEC , 31 (3) 346 - 354. 10.1002/hed.20974.

Chua, YL; Ito, Y; Pole, JCM; Newman, S; Chin, S-F; Stein, RC; Ellis, IO; (2009) The NRG1 gene is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene. ONCOGENE , 28 (46) pp. 4041-4052. 10.1038/onc.2009.259.

Cliffe, ST; Kramer, JM; Hussain, K; Robben, JH; de Jong, EK; de Brouwer, AP; Nibbeling, E; (2009) SLC29A3 gene is mutated in pigmented hypertrichosis with insulin-dependent diabetes mellitus syndrome and interacts with the insulin signaling pathway. HUM MOL GENET , 18 (12) 2257 - 2265. 10.1093/hmg/ddp161.

Coccia, M; Brooks, SP; Webb, TR; Christodoulou, K; Wozniak, IO; Murday, V; Balicki, M; (2009) X-linked cataract and Nance-Horan syndrome are allelic disorders. Hum Mol Genet , 18 (14) pp. 2643-2655.

Cohen, H; (2009) Anticoagulation: quality and safety indicators. [Lecture]. Presented at: Institute of healthcare management, London.

Cohen, H; (2009) Effectively implementing the NPSA safety alert. [Lecture]. Presented at: Institute of healthcare management conference on medication errors, London.

Cohen, H; (2009) Late obstetric morbidity in antiphospholipid syndrome. Presented at: VII European Forum on antiphospholipid antibodies, Marseilles.

Cohen, H; (2009) SHOT data 2008 Part 1. [Lecture]. Presented at: SHOT annual symposium, Royal Society of Medicine, London.

Cohen, H; Baglin, T; (2009) Plasma, plasma products and indications for their use. In: Contreras, M, (ed.) ABC of transfusion medicine: british medical journal books. (pp. 40-47). Wiley-Blackwell

Cohen, H; Gates, C; (2009) Anticoagulation therapy: quality and safety indicators. [Lecture]. Presented at: Institute of healthcare management, Manchester.

Cohen, H; Gates, C; (2009) Anticoagulation with dabigatran or rivaroxaban. Drugs and Therapeutics Bulletin , 47 pp. 116-120.

Cohen, H; Gates, C; (2009) New oral agents vs subcutaneous alternatives. Has the DTB drawn the correct conclusion? BMJ online

Cohen-Solal, A; Kotecha, D; van Veldhuisen, DJ; Babalis, D; Bohm, M; Coats, AJ; Roughton, M; (2009) Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial. EUR J HEART FAIL , 11 (9) 872 - 880. 10.1093/eurjhf/hfp104.

Collins, GP; Paterson, JC; Campbell, L; Mason, DY; Enver, T; Marafioti, T; (2009) EXPRESSION AND EPIGENETIC ANALYSIS OF KEY B-LINEAGE TRANSCRIPTIONAL PROGRAMMES IN HODGKIN/REED-STERNBERG CELLS. In: (Proceedings) 14th Annual Meeting of the European-Hematology-Association. (pp. p. 36). FERRATA STORTI FOUNDATION Gold open access

Constantinou, A; Epenetos, AA; Hreczuk-Hirst, D; Jain, S; Wright, M; Chester, KA; Deonarain, MP; (2009) Site-Specific Polysialylation of an Antitumor Single-Chain Fv Fragment. BIOCONJUGATE CHEM , 20 (5) 924 - 931. 10.1021/bc8005122.

Cooley, S; Trachtenberg, E; Bergemann, TL; Saeteurn, K; Klein, J; Le, CT; Marsh, SGE; (2009) Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia. BLOOD , 113 (3) pp. 726-732. 10.1182/blood-2008-07-171926.

Cowie, MR; Nicol, ED; Fittall, B; Roughton, M; Cleland, JGF; Dargie, H; (2009) Heart failure in the UK Reply. HEART , 95 (2) 156 - 157.

Croucher, C; Whelan, JS; Møller, H; Davies, EA; (2009) Trends in the incidence and survival of cancer in teenagers and young adults: Regional analysis for South East England 1960 - 2002. Clinical Oncology , 21 pp. 417-424.

Cunningham, D; Sirohi, B; Pluzanska, A; Utracka-Hutka, B; Zaluski, J; Glynne-Jones, R; Koralewski, P; (2009) Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer. Ann Oncol , 20 (2) pp. 244-250. 10.1093/annonc/mdn638.

D

Dalby, M; Kharbanda, R; Ghimire, G; Spiro, J; Moore, P; Roughton, M; Lane, R; (2009) Achieving routine sub 30 minute door-to-balloon times in a high volume 24/7 primary angioplasty center with autonomous ambulance diagnosis and immediate catheter laboratory access. AM HEART J , 158 (5) 829 - 835. 10.1016/j.ahj.2009.08.012.

Dancey, G; Begent, RH; Meyer, T; (2009) Imaging in targeted delivery of therapy to cancer. TARGET ONCOL , 4 (3) 201 - 217. 10.1007/s11523-009-0119-8.

Dancey, G; Violet, J; Malaroda, A; Green, AJ; Sharma, SK; Francis, R; Othman, S; (2009) A Phase I Clinical Trial of CHT-25 a I-131-Labeled Chimeric Anti-CD25 Antibody Showing Efficacy in Patients with Refractory Lymphoma. CLIN CANCER RES , 15 (24) 7701 - 7710. 10.1158/1078-0432.CCR-09-1421.

Dar, O; Riley, J; Chapman, C; Dubrey, SW; Morris, S; Rosen, SD; Roughton, M; (2009) A randomized trial of home telemonitoring in a typical elderly heart failure population in North West London: results of the Home-HF study. EUR J HEART FAIL , 11 (3) 319 - 325. 10.1093/eurjhf/hfn050.

Davies, TD; Taylor, C; Jones, H; Cohen, H; (2009) Serious hazards of transfusion (SHOT) near miss reporting. In: (Proceedings) British society for haematology annual scientific meeting.

Davies, TD; Taylor, C; Jones, H; Cohen, H; (2009) Serious hazards of transfusion (SHOT) reports relating to anti-D immunoglobulin. In: (Proceedings) British society for haematology annual scientific meeting.

Davis, R; Sielaff, A; Ruprich, J; Westrate, L; Tronrud, C; Ferguson, A; Brown, T; (2009) Design, synthesis, biophysical and biological studies of fluorescent Hoechst-polyamide hybrid molecules. ABSTR PAP AM CHEM S , 237 ? - ?.

Dearling, JLJ; Flynn, AA; Qureshi, U; Whiting, S; Boxer, GM; Green, A; Begent, RHJ; (2009) Localization of radiolabeled anti-CEA antibody in subcutaneous and intrahepatic colorectal xenografts: influence of tumor size and location within host organ on antibody uptake. NUCL MED BIOL , 36 (8) 883 - 894. 10.1016/j.nucmedbio.2009.07.003.

Delaney, D; Diss, TC; Presneau, N; Hing, S; Berisha, F; Idowu, BD; O'Donnell, P; (2009) GNAS1 mutations occur more commonly than previously thought in intramuscular myxoma. MODERN PATHOL , 22 (5) 718 - 724. 10.1038/modpathol.2009.32.

Denard, J; Rundwasser, S; Laroudie, N; Gonnet, F; Naldini, L; Radrizzani, M; Galy, A; (2009) Quantitative proteomic analysis of lentiviral vectors using 2-DE. Proteomics , 9 (14) pp. 3666-3676. 10.1002/pmic.200800747.

Dennis, MY; Paracchini, S; Scerri, TS; Prokunina-Olsson, L; Knight, JC; Wade-Martins, R; Coggill, P; (2009) A Common Variant Associated with Dyslexia Reduces Expression of the KIAA0319 Gene. PLOS GENET , 5 (3) , Article e1000436. 10.1371/journal.pgen.1000436. Green open access
file

Desai, K; Bhattacharya, S; Srirajaskanthan, R; Morgan-Rowe, L; Toumpanakis, C; Meyer, T; Caplin, M; (2009) Analysis of association between carcinoid heart disease and mesenteric fibrosis in patients with midgut carcinoid tumour. In: (Proceedings) 45th Annual Meeting of the American-Society-of-Clinical-Oncology. AMER SOC CLINICAL ONCOLOGY

Desai, K; Bhattacharya, S; Srirajaskanthan, R; Morgan-Rowe, L; Toumpanakis, C; Meyer, T; Caplin, M; (2009) Analysis of association between carcinoid heart disease and mesenteric fibrosis in patients with midgut carcinoid tumour. J Clin Oncol , 27 (15_suppl) , Article e15650.

Dignan, FL; Anthias, C; Ethell, ME; Morilla, R; Morilla, A; Davies, FE; Morgan, GJ; (2009) The Presence of Minimal Residual Disease Pre- and Post-Transplant Is Predictive of Outcome in Recipients of Allogeneic Transplantation for Acute Myeloid Leukaemia. In: BLOOD. (pp. 1020 - 1021). AMER SOC HEMATOLOGY

Dignan, FL; Evans, SO; Ethell, ME; Shaw, BE; Davies, FE; Dearden, CE; Treleaven, JG; (2009) An early CT-diagnosis-based treatment strategy for invasive fungal infection in allogeneic transplant recipients using caspofungin first line: an effective strategy with low mortality. BONE MARROW TRANSPL , 44 (1) 51 - 56. 10.1038/bmt.2008.427.

Ding, XY; Patel, M; Shen, DF; Herzlich, AA; Cao, XG; Villasmil, R; Klupsch, K; (2009) Enhanced HtrA2/Omi Expression in Oxidative Injury to Retinal Pigment Epithelial Cells and Murine Models of Neurodegeneration. INVEST OPHTH VIS SCI , 50 (10) 4957 - 4966. 10.1167/iovs.09-3381.

Dovey, CL; Aslanian, A; Sofueva, S; Yates, JR; Russell, P; (2009) Mms1-Mms22 complex protects genome integrity in Schizosaccharomyces pombe. DNA REPAIR , 8 (12) 1390 - 1399. 10.1016/j.dnarep.2009.09.008.

Dulev, S; de Renty, C; Mehta, R; Minkov, I; Schwob, E; Strunnikov, A; (2009) Essential global role of CDC14 in DNA synthesis revealed by chromosome underreplication unrecognized by checkpoints in cdc14 mutants. Proc Natl Acad Sci U S A , 106 (34) pp. 14466-14471. 10.1073/pnas.0900190106.

Dunn, JM; Fullarton, G; Thorpe, S; Novelli, M; Bown, SG; Lovat, LB; (2009) RADIOFREQUENCY ABLATION OF HIGH-GRADE DYSPLASIA IN BARRETT’S OESOPHAGUS AFTER FAILED PHOTODYNAMIC THERAPY: FIRST RESULTS OF THE UK HALO RADIOFREQUENCY ABLATION REGISTRY. In: (pp. PT286-).

Dunn, JM; Fullarton, GM; Thorpe, S; Novelli, M; Bown, SG; Lovat, L; (2009) Radiofrequency Ablation of High Grade Dysplasia in Barrett's Oesophagus Is Safe and Effective After Failed Photodynamic Therapy - First Results of the UK HALO RFA Registry. In: GASTROINTESTINAL ENDOSCOPY. (pp. AB260 - AB260). MOSBY-ELSEVIER

Dunn, JM; Mackenzie, GD; Oukrif, D; Green, SJ; Chew, Y; Mosse, CA; Thorpe, S; (2009) DNA Ploidy As a Prognostic Biomarker After Ala Photodynamic Therapy for High Grade Dysplasia in Barrett's Oesophagus. In: GASTROENTEROLOGY. (pp. A49 - A49). W B SAUNDERS CO-ELSEVIER INC

Dunn, JM; Mackenzie, GD; Oukrif, D; Mosse, CA; Green, S; Chew, Y; Thorpe, S; (2009) DNA PLOIDY AS A PROGNOSTIC BIOMARKER AFTER AMINOLEVULINIC ACID PHOTODYNAMIC THERAPY FOR HIGH-GRADE DYSPLASIA IN BARRETT'S OESOPHAGUS. In: GUT. (pp. A111 - A112). B M J PUBLISHING GROUP

Dunn, JM; Mackenzie, GD; Oukrif, D; Mosse, CA; Green, S; Chew, Y; Thorpe, S; (2009) DNA PLOIDY AS A PROGNOSTIC BIOMARKER AFTER AMINOLEVULINIC ACID PHOTODYNAMIC THERAPY FOR HIGH-GRADE DYSPLASIA IN BARRETT’S OESOPHAGUS. In: (pp. PT285-).

Dunn, JM; Thorpe, S; Novelli, M; Bown, SG; Lovat, L; (2009) Radiofrequency Ablation for the Treatment of Squamous High Grade Dysplasia of the Oesophagus- First Reported Series. In: GASTROINTESTINAL ENDOSCOPY. (pp. AB255 - AB255). MOSBY-ELSEVIER

Durand, CA; Hartvigsen, K; Fogelstrand, L; Kim, S; Iritani, S; Vanhaesebroeck, B; Witztum, JL; (2009) Phosphoinositide 3-kinase p110 delta regulates natural antibody production, marginal zone and B-1 B cell function, and autoantibody responses. J Immunol , 183 (9) pp. 5673-5684. 10.4049/jimmunol.0900432.

de Fabiani, E; Gilardi, F; Galmozzi, A; Boraso, M; Bartesaghi, S; Torri, A; Caruso, D; (2009) EXPRESSION OF STEROL 27-HYDROXYLASE IN GLIAL CELLS AND ITS REGULATION BY LIVER X RECEPTOR SIGNALING. In: GLIA. (pp. S51 - S51). WILEY-LISS

E

Edinger, M; Powrie, F; Chakraverty, R; (2009) Regulatory Mechanisms in Graft-versus-Host Responses. Biology of Blood and Marrow Transplantation , 15 (1 SUPPL.) pp. 2-6. 10.1016/j.bbmt.2008.10.013.

El-Mehidi, N.S.; (2009) Bayesian network models of interdependent chromosomal aberrations in unstable cancer genomes. Doctoral thesis, UCL (University College London).

Ella, W; Short, SC; (2009) Using retinoids to increase radio-iodine uptake in thyroid cancer: role as potential redifferentiation agents. In: The handbook on iodine. Elsevier

Emuss, V; Lagos, D; Pizzey, A; Gratrix, F; Henderson, SR; Boshoff, C; (2009) KSHV Manipulates Notch Signaling by DLL4 and JAG1 to Alter Cell Cycle Genes in Lymphatic Endothelia. PLoS Pathogens , 5 (10) , Article e1000616. 10.1371/journal.ppat.1000616. Green open access
file

Endrighi, R; Hamer, M; O'Donnell, K; Steptoe, A; (2009) Optimism is associated with lower daily cortisol production in healthy older men and women. PSYCHOLOGY & HEALTH , 24 pp. 163-164.

Enver, T; Jacobsen, SEW; (2009) DEVELOPMENTAL BIOLOGY Instructions writ in blood. NATURE , 461 (7261) pp. 183-184. 10.1038/461183a.

Enver, T; Pera, M; Peterson, C; Andrews, PW; (2009) Stem Cell States, Fates, and the Rules of Attraction. CELL STEM CELL , 4 (5) pp. 387-397. 10.1016/j.stem.2009.04.011.

Essafi, A; Gomes, AR; Pomeranz, KM; Zwolinska, AK; Varshochi, R; McGovern, UB; Lam, EW-F; (2009) Studying the subcellular localization and DNA-binding activity of FoxO transcription factors, downstream effectors of PI3K/Akt. Methods Mol Biol , 462 pp. 201-211. 10.1007/978-1-60327-115-8_13.

Everington, T.; (2009) Investigation of the molecular and functional pathophysiology of polycythaemia vera. Doctoral thesis, UCL (University College London).

F

FOLEY, JH; NESHEIM, ME; (2009) Soluble thrombomodulin partially corrects the premature lysis defect in FVIII-deficient plasma by stimulating the activation of thrombin activatable fibrinolysis inhibitor. Journal of Thrombosis and Haemostasis , 7 (3) pp. 453-459. 10.1111/j.1538-7836.2008.03261.x.

Fallah-Arani, F; Sivakumaran, J; Flutter, BR; Bennett, C; Chakraverty, R; (2009) Host CD11c(+) Dendritic Cells Are Required for Priming the Lympho-Haematopoietic Graft-Versus-Host Response but Not Graft-Versus-Host Disease. In: BLOOD. (pp. 966 - 967). AMER SOC HEMATOLOGY

Fazel, MZ; Gogalniceanu, P; Patel, A; Capitano, A; Kocjan, G; Falzon, M; Douek, M; (2009) Intra-operative touch imprint cytology for assessing sentinel lymph nodes in patients with lobular breast cancer. In: CANCER RESEARCH. (pp. 108S - 108S). AMER ASSOC CANCER RESEARCH

Fern, L; Ashton, J; Broonan, K; Irving, C; Millington, H; Starkey, C; Wright, D; (2009) Involving young people with cancer in research. The National Cancer Research Institute’s Teeange and Young Adult Core Consumer Group – a new and evolving model. In:

Fielding, AK; Rowe, JM; Richards, SM; Buck, G; Moorman, AV; Durrant, IJ; Marks, DI; (2009) Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International ALL Trial MRC UKALLXII/ECOG2993. BLOOD , 113 (19) 4489 - 4496. 10.1182/blood-2009-01-199380.

Finerty, MJ; Bingham, JP; Hartley, JA; Shipman, M; (2009) Azinomycin bisepoxides containing rigid aromatic linkers: synthesis, cytotoxicity and DNA interstrand cross-linking activity. TETRAHEDRON LETT , 50 (26) 3648 - 3650. 10.1016/j.tetlet.2009.03.123.

Fiore, MM; Mackie, IJ; (2009) Dual effect of Platelet Factor 4 on the activities of Factor Xa. BIOCHEM BIOPH RES CO , 379 (4) 1072 - 1075. 10.1016/j.bbrc.2009.01.016.

Fiore, MM; Mackie, IM; (2009) Mechanism of low-molecular-weight heparin reversal by platelet factor 4. THROMBOSIS RESEARCH , 124 (1) pp. 149-155. 10.1016/j.thromres.2008.12.047.

Flanagan, JM; Funes, JM; Henderson, S; Wild, L; Carey, N; Boshoff, C; (2009) Genomics screen in transformed stem cells reveals RNASEH2A, PPAP2C, and ADARB1 as putative anticancer drug targets. MOL CANCER THER , 8 (1) 249 - 260. 10.1158/1535-7163.MCT-08-0636.

Flanagan, JM; Munoz-Alegre, M; Henderson, S; Tang, T; Sun, P; Johnson, N; Fletcher, O; (2009) Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients. HUM MOL GENET , 18 (7) 1332 - 1342. 10.1093/hmg/ddp033.

Fong, LY; Wan, SG; Taccioli, C; Jiang, YB; Liu, XP; Croce, CM; Farber, JL; (2009) Zinc Deficiency Induces Upregulation of S100A8/A9 and Abolishes the Anticancer Effects of COX-2 Disruption in Murine Oral-Esophageal Cancer Prevention. J NUTRIGENET NUTRIGE , 2 (4-5) 211 - 211.

Ford, AM; Palmi, C; Bueno, C; Hong, D; Cardus, P; Knight, D; Cazzaniga, G; (2009) The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells. JOURNAL OF CLINICAL INVESTIGATION , 119 (4) pp. 826-836. 10.1172/JCI36428.

Foroni, L; Gerrard, G; Nna, E; Khorashad, JS; Stevens, D; Swale, B; Milojkovic, D; (2009) Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia. AMERICAN JOURNAL OF HEMATOLOGY , 84 (8) pp. 517-522. 10.1002/ajh.21457.

Forshew, T; Tatevossian, RG; Lawson, ARJ; Ma, J; Neale, G; Ogunkolade, BW; Jones, TA; (2009) Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas. J Pathol , 218 (2) pp. 172-181. 10.1002/path.2558.

Fox, J; Patkar, V; Chronakis, I; Begent, R; (2009) From practice guidelines to clinical decision support: closing the loop. J ROY SOC MED , 102 (11) 464 - 473. 10.1258/jrsm.2009.090010.

Francis, RE; Myatt, SS; Krol, J; Hartman, J; Peck, B; McGovern, UB; Wang, J; (2009) FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer. Int J Oncol , 35 (1) pp. 57-68.

G

GUPTA, R; Vyas, P; Enver, T; (2009) Molecular targeting of cancer stem cells. Cell Stem Cell , 5 (2) pp. 125-126. 10.1016/j.stem.2009.07.006.

Gancheva, K; Postadjian, A; Brazma, D; Grace, C; Chanalaris, A; Nacheva, E; Apostolova, MD; (2009) COPY NUMBER VARIANTS: DISTRIBUTION IN PATIENTS WITH CORONARY ATHEROSCLEROSIS. BIOTECHNOL BIOTEC EQ , 23 (1) 1095 - 1100.

Gandhi, S; Wood-Kaczmar, A; Yao, Z; Plun-Favreau, H; Deas, E; Klupsch, K; Downward, J; (2009) PINK1-Associated Parkinson's Disease Is Caused by Neuronal Vulnerability to Calcium-induced Cell Death. MOL CELL , 33 (5) 627 - 638. 10.1016/j.molcel.2009.02.013. Gold open access

Garbowski, MW; Carpenter, JP; Smith, G; Pennell, DJ; Porter, JB; (2009) Calibration of Improved T2*Method for the Estimation of Liver Iron Concentration in Transfusional Iron Overload. In: BLOOD. (pp. 791 - 791). AMER SOC HEMATOLOGY

Garbowski, MW; Fabre, M; Evans, P; Porter, JB; (2009) Vitamin C Status in Transfusionally Iron-Overloaded Patients On Long-Term Deferasirox and Its Relationship to Myocardial Iron Removal. In: BLOOD. (pp. 792 - 792). AMER SOC HEMATOLOGY

Gardiner, C; Longair, I; Pescott, MA; Erwin, H; Hills, J; Machin, SJ; Cohen, H; (2009) Self-monitoring of oral anticoagulation: does it work outside trial conditions? Journal of Clinical Pathology , 62 (2) 168 - 171. 10.1136/jcp.2008.059634. Green open access
file

Gardiner, C; Machin, S; Mackie, I; (2009) Point-of-Care Testing in Hemostasis. In: Quality in Laboratory Hemostasis and Thrombosis. (pp. 72-80).

Garofalo, M; Di Leva, G; Romano, G; Nuovo, G; Suh, SS; Ngankeu, A; Taccioli, C; (2009) miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation. CANCER CELL , 16 (6) 498 - 509. 10.1016/j.ccr.2009.10.014.

Gaya, A.M.; (2009) Combination therapy studies with the vascular disruptive agent combretastatin-a4-phosphate (CA4P). Doctoral thesis, UCL (University College London). Green open access
file

Gennarino, VA; Sardiello, M; Avellino, R; Meola, N; Maselli, V; Anand, S; Cutillo, L; (2009) MicroRNA target prediction by expression analysis of host genes. pp. 481-490.

George, S; Lal, R; Camidge, DR; Arkenau, H; Chick, J; Poondru, S; Yap, TA; (2009) Final results of a dose escalation (DE), pharmacokinetic (PK), and pharmacodynamic (PD) study of two schedules of OSI-930 in patients (pts) with advanced solid tumors. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. ? - ?). AMER SOC CLINICAL ONCOLOGY

Gerrard, G; Butters, TD; Ganeshaguru, K; Mehta, AB; (2009) Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity. EUROPEAN JOURNAL OF PHARMACOLOGY , 609 (1-3) pp. 34-39. 10.1016/j.ejphar.2009.03.018.

Ghimire, G; Spiro, J; Kharbanda, R; Roughton, M; Barlis, P; Mason, M; Ilsley, C; (2009) Initial evidence for the return of coronary vasoreactivity following the absorption of bioabsorbable magnesium alloy coronary stents. EuroIntervention , 4 (4) pp. 481-484.

Ghosh, AK; Shanafelt, TD; Cimmino, A; Taccioli, C; Volinia, S; Liu, CG; Calin, GA; (2009) Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells. BLOOD , 113 (22) 5568 - 5574. 10.1182/blood-2008-10-185686.

Giampieri, S; Manning, C; Hooper, S; Jones, L; Hill, CS; Sahai, E; (2009) Localized and reversible TGF beta signalling switches breast cancer cells from cohesive to single cell motility. NAT CELL BIOL , 11 (11) 1287 - U49. 10.1038/ncb1973.

Gibson, F; Aldiss, S; Taylor, RM; Maguire, R; Kearney, N; (2009) Involving health professionals in the development of an advanced symptom management system for young people: The ASyMS (c)-YG study. EUR J ONCOL NURS , 13 (3) 187 - 192. 10.1016/j.ejon.2009.03.004.

Gibson, F; Pearce, S; Eden, T; Glaser, A; Hooker, L; Whelan, J; Kelly, D; (2009) CANCER IN YOUNG PEOPLE: A NARRATIVE STUDY TO EXPLORE THEIR EXPERIENCE FROM FIRST SYMPTOMS TO THE DIAGNOSIS OF CANCER. In: PEDIATR BLOOD CANCER. (pp. 751 - 751). WILEY-LISS

Gikas, PD; Islam, L; Aston, W; Tirabosco, R; Saifuddin, A; Briggs, TWR; Cannon, SR; (2009) Nonbacterial osteitis: a clinical, histopathological, and imaging study with a proposal for protocol-based management of patients with this diagnosis. J ORTHOP SCI , 14 (5) 505 - 516. 10.1007/s00776-009-1381-4.

Gilardi, F; Viviani, B; Galmozzi, A; Boraso, M; Bartesaghi, S; Torri, A; Caruso, D; (2009) EXPRESSION OF STEROL 27-HYDROXYLASE IN GLIAL CELLS AND ITS REGULATION BY LIVER X RECEPTOR SIGNALING. NEUROSCIENCE , 164 (2) 530 - 540. 10.1016/j.neuroscience.2009.08.003.

Gollmer, K; Asperti-Boursin, F; Tanaka, Y; Okkenhaug, K; Vanhaesebroeck, B; Peterson, JR; Fukui, Y; (2009) CCL21 mediates CD4+ T-cell costimulation via a DOCK2/Rac-dependent pathway. Blood , 114 (3) pp. 580-588. 10.1182/blood-2009-01-200923.

Gordon, WR; Roy, M; Vardar-Ulu, D; Garfinkel, M; Mansour, MR; Aster, JC; Blacklow, SC; (2009) Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL. BLOOD , 113 (18) pp. 4381-4390. 10.1182/blood-2008-08-174748.

Gourley, C; Paige, AJW; Taylor, KJ; Ward, C; Kuske, B; Zhang, J; Sun, M; (2009) WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3. Cancer Res , 69 (11) pp. 4835-4842. 10.1158/0008-5472.CAN-08-2974.

Graf, T; Enver, T; (2009) Forcing cells to change lineages. NATURE , 462 (7273) pp. 587-594. 10.1038/nature08533.

Green, CL; Koo, KK; Hills, RK; Burnett, AK; Linch, DC; Gale, RE; (2009) PROGNOSTIC SIGNIFICANCE OF CEBPA MUTATIONS IN A LARGE COHORT OF YOUNGER ADULT PATIENTS WITH AML: IMPACT OF DOUBLE CEBPA MUTATIONS AND THE INTERACTION WITH FLT3 AND NPM1 MUTATIONS. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 431 - 431). FERRATA STORTI FOUNDATION Gold open access

Grimwade, D; Jovanovic, JV; Hills, RK; Nugent, EA; Patel, Y; Flora, R; Diverio, D; (2009) Prospective Minimal Residual Disease Monitoring to Predict Relapse of Acute Promyelocytic Leukemia and to Direct Pre-Emptive Arsenic Trioxide Therapy. J CLIN ONCOL , 27 (22) 3650 - 3658. 10.1200/JCO.2008.20.1533.

Grun, B; Benjamin, E; Sinclair, J; Timms, JF; Jacobs, IJ; Gayther, SA; Dafou, D; (2009) Three-dimensional in vitro cell biology models of ovarian and endometrial cancer. CELL PROLIFERAT , 42 (2) 219 - 228. 10.1111/j.1365-2184.2008.00579.x.

Gunaratnam, M; Green, C; Moreira, JB; Moorhouse, AD; Kelland, LR; Moses, JE; Neidle, S; (2009) G-quadruplex compounds and cis-platin act synergistically to inhibit cancer cell growth in vitro and in vivo. Biochem Pharmacol , 78 (2) pp. 115-122.

Gunaratnam, M; Swank, S; Haider, SM; Galesa, K; Reszka, AP; Beltran, M; Cuenca, F; (2009) Targeting human gastrointestinal stromal tumor cells with a quadruplex-binding small molecule. J Med Chem , 52 (12) pp. 3774-3783. 10.1021/jm900424a.

Gupta, R; Vyas, P; Enver, T; (2009) Molecular Targeting of Cancer Stem Cells. CELL STEM CELL , 5 (2) pp. 125-126. 10.1016/j.stem.2009.07.006.

H

Haas, TL; Emmerich, CH; Gerlach, B; Schmukle, AC; Cordier, SM; Rieser, E; Feltham, R; (2009) Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol Cell , 36 pp. 831-844. 10.1016/j.molcel.2009.10.013.

Hackshaw, A; (2009) Luteinizing hormone-releasing hormone (LHRH) agonists in the treatment of breast cancer. Expert Opinion on Pharmacotherapy , 10 (16) pp. 1-7.

Hackshaw, A; (2009) A concise guide to clinical trials. [Book]. (1st ed.). BMJ Books (Blackwell & John Wiley Publishing)

Hackshaw, A; (2009) The NCRI prospective randomised trial of high (standard) versus low dose 131I ablation with or without recombinant TSH (HiLo). In: Miles, A, (ed.) The effective management of head, neck and thyroid cancer. UK Key Advances in Clinical Practice. Aesculapius Medical Press (In press).

Hackshaw, A; Baum, M; Fornander, T; Nordenskjold, B; Nicolucci, A; Monson, K; Forsyth, S; (2009) Long-term Effectiveness of Adjuvant Goserelin in Premenopausal Women With Early Breast Cancer. J NATL CANCER I , 101 (5) 341 - 349. 10.1093/jnci/djn498. Green open access
file

Hackshaw, AK; Mallick, U; (2009) Low versus high I-131 dose for remnant ablation in differentiated thyroid cancer. Clinical Medicine and Research , 7 (1/2) pp. 1-3.

Hadjur, S; Bruno, L; Hertweck, A; Cobb, BS; Taylor, B; Fisher, AG; Merkenschlager, M; (2009) IL4 blockade of inducible regulatory T cell differentiation: The role of Th2 cells, Gata3 and PU.1. IMMUNOL LETT , 122 (1) 37 - 43. 10.1016/j.imlet.2008.11.001.

Hadjur, S; Williams, LM; Ryan, NK; Cobb, BS; Sexton, T; Fraser, P; Fisher, AG; (2009) Cohesins form chromosomal cis-interactions at the developmentally regulated IFNG locus. NATURE , 460 (7253) 410 - U130. 10.1038/nature08079.

Hall, JRAS; SC, ; (2009) Management of Glioblastoma Multiforme in HIV patients: a case series and review of published studies. Clinical Oncology

Hamer, M; O'Donnell, K; Steptoe, A; Lahiri, A; (2009) Neuroendocrine function and sub-clinical atherosclerosis in healthy adults. In: (Proceedings) 22nd Congress of the European-College-of-Neuropsychopharmacology. (pp. S198-S198). ELSEVIER SCIENCE BV

Hancock, BW; Qian, W; Linch, D; Delchier, J-C; Smith, P; Jakupovic, I; Burton, C; (2009) Chlorambucil versus observation after anti-Helicobacter therapy in gastric MALT lymphomas: results of the international randomised LY03 trial. BRITISH JOURNAL OF HAEMATOLOGY , 144 (3) pp. 367-375. 10.1111/j.1365-2141.2008.07486.x.

Harland, SJ; Welch, R; Huddart, R; Stenning, S; Pollock, P; Gabe, R; (2009) On the necessity for postchemotherapy surgery for residual abdominal masses in metastatic nonseminomatous germ cell tumors (NSGCT) of testis. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. ? - ?). AMER SOC CLINICAL ONCOLOGY

Harten, SK; Shukla, D; Barod, R; Hergovich, A; Balda, MS; Matter, K; Esteban, MA; (2009) Regulation of Renal Epithelial Tight Junctions by the von Hippel-Lindau Tumor Suppressor Gene Involves Occludin and Claudin 1 and Is Independent of E-Cadherin. MOL BIOL CELL , 20 (3) 1089 - 1101. 10.1091/mbc.E08-06-0566.

Hatton, C; Peniket, A; Tusold, A; Collins, G; Joyner, M; Lee, R; Mouncey, P; (2009) Single arm phase II open label study of thalidomide in patients with refractory or relapsed diffuse large B cell lymphoma. In: (Proceedings) 49th Annual Scientific Meeting/British Society for Haematology, Brighton.. (pp. 13-). British Journal of Haematology

Hatton, CSR; Peniket, A; Tusold, A; Collins, GP; Joyner, M; Lee, R; Mouncey, P; (2009) Single arm phase II open label study of thalidomide in patients with refractory or relapsed diffuse large B cell lymphoma. In: (Proceedings) 49th Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 13). WILEY-BLACKWELL PUBLISHING, INC

Henriquez, N; Jacques, TS; Swales, A; Brandner, S; (2009) Stem cells, progenitor cells and brain tumours: how related are they? In: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. (pp. 4 - 4). BLACKWELL PUBLISHING

Hergovich, A; Hemmings, BA; (2009) Mammalian NDR/LATS protein kinases in hippo tumor suppressor signaling. BIOFACTORS , 35 (4) 338 - 345. 10.1002/biof.47.

Hergovich, A; Kohler, RS; Schmitz, D; Vichalkovski, A; Cornils, H; Hemmings, BA; (2009) The MST1 and hMOB1 Tumor Suppressors Control Human Centrosome Duplication by Regulating NDR Kinase Phosphorylation. CURR BIOL , 19 (20) 1692 - 1702. 10.1016/j.cub.2009.09.020.

Hewish, M; Miller, R; Forster, MD; Smith, IE; (2009) Severe synergistic toxicity from docetaxel in a patient treated concurrently with protease inhibitors as part of HIV-exposure prophylaxis: a case report. Journal of Medical Case Reports , 3 8866-.

Hillmen, P; Gribben, JG; Follows, GA; Milligan, DW; Sayala, HA; Moreton, P; Oscier, D; (2009) An Open-Label Phase II Study to Investigate the Safety and Efficacy of Rituximab Plus Chlorambucil in Previously Untreated Patients with CD20-Positive B-Cell Chronic Lymphocytic Leukaemia (CLL). In: BLOOD. (pp. 1331 - 1332). AMER SOC HEMATOLOGY

Hochhauser, D; Meyer, T; Spanswick, VJ; Wu, J; Clingen, PH; Loadman, P; Cobb, M; (2009) Phase I Study of Sequence-Selective Minor Groove DNA Binding Agent SJG-136 in Patients with Advanced Solid Tumors. CLIN CANCER RES , 15 (6) 2140 - 2147. 10.1158/1078-0432.CCR-08-1315.

Hochhauser, D; Meyer T, L; P, S; V J, C; M, B; R H, W; J, C; (2009) Phase I study of the DNA minor groove binding pyrrolobenzodiazepine dimer (SJG 136) administered every 21 days in patients with advanced solid tumours. Clinical Cancer Research , 15 (6) pp. 2140-2147.

Holdsworth, R; Hurley, CK; Marsh, SGE; Lau, M; Noreen, HJ; Kempenich, JH; Setterholm, M; (2009) The HLA dictionary 2008: a summary of HLA-A, -B, -C,-DRB1/3/4/5, and-DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. TISSUE ANTIGENS , 73 (2) pp. 95-170. 10.1111/j.1399-0039.2008.01183.x.

Holmes, MV; Mehta, A; Morgan, MY; (2009) Hemiparesis in a 36 year old man. BMJ (Online) , 338 (7691) 419-. 10.1136/bmj.b90.

Holroyd, A; Townsend, W; Naik, P; Mackinnon, S; Howell, D; Goldstone, A; Linch, D; (2009) Favourable outcome for allogeneic haematopoietic transplant recipients requiring intensive therapy unit admission with improved survival following reduced intensity conditioning. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 42 - 42). WILEY-BLACKWELL PUBLISHING, INC

Holroyd, A; Townsend, W; Naik, P; Mackinnon, S; Howell, D; Goldstone, A; Linch, D; (2009) Favourable outcome for haematopoietic transplant recipients requiring intensive therapy unit admission: a 10-year single-centre experience. In: BONE MARROW TRANSPLANTATION. (pp. S23 - S23). NATURE PUBLISHING GROUP

Hoskin, PJ; Lowry, L; Horwich, A; Jack, A; Mead, B; Hancock, BW; Smith, P; (2009) Randomized Comparison of the Stanford V Regimen and ABVD in the Treatment of Advanced Hodgkin's Lymphoma: United Kingdom National Cancer Research Institute Lymphoma Group Study ISRCTN 64141244. In: (Proceedings) 50th Annual Meeting of the American-Society-of-Hematology. (pp. pp. 5390-5396). AMER SOC CLINICAL ONCOLOGY

Hough, R; Cooper, N; Veys, P; (2009) Allogeneic haemopoietic stem cell transplantation in children: what alternative donor should we choose when no matched sibling is available? BRITISH JOURNAL OF HAEMATOLOGY , 147 (5) pp. 593-613. 10.1111/j.1365-2141.2009.07841.x.

Howard, PW; Chen, Z; Gregson, SJ; Masterson, L; Tiberghien, AC; Cooper, N; Fang, M; (2009) Synthesis of a novel C2/C2?-aryl-substituted pyrrolo[2,1-c][1,4]benzodiazepine dimer prodrug with improved water solubility and reduced DNA reaction rate. Biorganic and Medicinal Chemistry Letters , 19 (22) pp. 6463-6466. 10.1016/j.bmcl.2009.09.012.

Howie, AJ; Brewer, DB; (2009) Optical properties of amyloid stained by Congo red: history and mechanisms. Micron , 40 (3) pp. 285-301. 10.1016/j.micron.2008.10.002.

Huang, Y; Moreau, A; Dupuis, J; Streubel, B; Petit, B; Le Gouill, S; Martin-Garcia, N; (2009) Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas. Am J Surg Pathol , 33 (5) pp. 682-690. 10.1097/PAS.0b013e3181971591.

Hubacek, P; Virgili, A; Ward, KN; Pohlreich, D; Keslova, P; Goldova, B; Markova, M; (2009) HHV-6 DNA throughout the tissues of two stem cell transplant patients with chromosomally integrated HHV-6 and fatal CMV pneumonitis. BRIT J HAEMATOL , 145 (3) 394 - 398. 10.1111/j.1365-2141.2009.07622.x.

Hubbard, TJP; Aken, BL; Ayling, S; Ballester, B; Beal, K; Bragin, E; Brent, S; (2009) Ensembl 2009. NUCLEIC ACIDS RESEARCH , 37 D690-D697. 10.1093/nar/gkn828. Gold open access

Huggett, JF; Taylor, MS; Kocjan, G; (2009) Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients (vol 63, pg 154, 2008). THORAX , 64 (7) 643 - 643.

Hughes, C; Mcewan, JR; Longair, I; Hughes, S; Cohen, H; Machin, S; Scully, M; (2009) Cardiac involvement in acute thrombotic thrombocytopenic purpura: association with troponin T and IgG antibodies to ADAMTS 13. J THROMB HAEMOST , 7 (4) 529 - 536. 10.1111/j.1538-7836.2009.03285.x.

Hughes, D; (2009) The Management of Gaucher Disease as a Chronic Disorder. In: CLINICAL THERAPEUTICS. (pp. S182 - S182). ELSEVIER

Hughes, DA; (2009) Enzyme, substrate, and myeloma in Gaucher Disease. AM J HEMATOL , 84 (4) 199 - 201. 10.1002/ajh.21375.

Hussain, K; Padidela, R; Kapoor, RR; James, C; Banerjee, K; Harper, J; Wilson, LC; (2009) Diabetes mellitus, exocrine pancreatic deficiency, hypertrichosis, hyperpigmentation, and chronic inflammation: confirmation of a syndrome. PEDIATR DIABETES , 10 (3) 193 - 197. 10.1111/j.1399-5448.2008.00470.x.

I

Iatan, I; Bailey, D; Hafiane, A; Zanesi, N; Taccioli, C; Abu Odeh, M; Pajukanta, P; (2009) Deficiency of the WW Domain-Containing Oxidoreductase (WWOX) Impairs the HDL Biogenesis Pathway. In: CIRCULATION. (pp. S476 - S477). LIPPINCOTT WILLIAMS & WILKINS

Isgro, G; Colvaruso, V; Manousou, P; Luong, TV; Andreana, L; Patch, DW; Davies, N; (2009) CORRELATION OF ISHAK STAGE,TRANSIENT ELASTOGRAPHY,HVPG AND COLLAGEN PROPORTIONATE AREA IN HCV TRANSPLANTED PATIENTS. In: HEPATOLOGY. (pp. 481A - 482A). JOHN WILEY & SONS INC

J

James, C; Kapoor, RR; Ismail, D; Hussain, K; (2009) The genetic basis of congenital hyperinsulinism. J MED GENET , 46 (5) 289 - 299. 10.1136/jmg.2008.064337.

James, R; Wan, S; Glynne-Jones, R; Sebag-Montefiore, D; Kadalayil, L; Northover, J; Cunningham, D; (2009) A randomized trial of chemoradiation using mitomycin or cisplatin, with or without maintenance cisplatin/5FU in squamous cell carcinoma of the anus (ACT II). In: (Proceedings) 45th Annual Meeting of the American-Society-of-Clinical-Oncology. AMER SOC CLINICAL ONCOLOGY

James, R; Wan, S; Glynne-Jones, R; Sebag-Montefiore, D; Kadalayil, L; Northover, J; Cunningham, D; (2009) A randomized trial of chemoradiation using mitomycin or cisplatin, with or without maintenance cisplatin/5FU in squamous cell carcinoma of the anus (ACT II). J Clin Oncol , 27 (18_suppl) LBA4009-.

James, R; Wan, S; Glynne-Jones, R; Sebag-Montefiore, D; Kadalayil, L; Northover, J; Cunningham, D; (2009) A randomized trial of chemoradiation using mitomycin or cisplatin, with or without maintenance cisplatin/5FU in squamous cell carcinoma of the anus (ACT II). J Clin Oncol , 27 (15_suppl) LBA4009-.

Jenner, RG; Townsend, MJ; Jackson, I; Sun, KM; Bouwman, RD; Young, RA; Glimcher, LH; (2009) The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genes. P NATL ACAD SCI USA , 106 (42) 17876 - 17881. 10.1073/pnas.0909357106. Gold open access

Jennings, B; Harvey, R; Ish-Horowicz, D; (2009) Regulation of transcriptional elongation by spt5 during drosophila development. In: MECHANISMS OF DEVELOPMENT. (pp. S114 - S114). ELSEVIER SCIENCE BV

Joly, P; Jennings, BH; Jayasinghe, SN; (2009) Development and fertility studies on post-bio-electrosprayed Drosophila melanogaster embryos. BIOMICROFLUIDICS , 3 (4) , Article 044107. 10.1063/1.3267044.

K

Kalambokis, G; Manousou, P; Samonakis, D; Grillo, F; Dhillon, AP; Patch, D; O'Beirne, J; (2009) Clinical outcome of HCV-related graft cirrhosis and prognostic value of hepatic venous pressure gradient. TRANSPL INT , 22 (2) 172 - 181. 10.1111/j.1432-2277.2008.00744.x.

Kapoor, RR; Flanagan, SE; James, C; Shield, J; Ellard, S; Hussain, K; (2009) Hyperinsulinaemic hypoglycaemia. ARCH DIS CHILD , 94 (6) 450 - 457. 10.1136/adc.2008.148171.

Kapoor, RR; James, C; Flanagan, SE; Ellard, S; Eaton, S; Hussain, K; (2009) 3-Hydroxyacyl-Coenzyme A Dehydrogenase Deficiency and Hyperinsulinemic Hypoglycemia: Characterization of a Novel Mutation and Severe Dietary Protein Sensitivity. J CLIN ENDOCR METAB , 94 (7) 2221 - 2225. 10.1210/jc.2009-0423.

Kapoor, RR; James, C; Hussain, K; (2009) Advances in the diagnosis and management of hyperinsulinemic hypoglycemia. NAT CLIN PRACT ENDOC , 5 (2) 101 - 112. 10.1038/ncpendmet1046.

Kapoor, RR; James, C; Hussain, K; (2009) Advances in the diagnosis and management of hyperinsulinemic hypoglycemia. Nature Clinical Practice Endocrinology & Metabolism , 5 (3) p. 180. 10.1038/ncpendmet1096.

Kapoor, RR; James, C; Hussain, K; (2009) Hyperinsulinism in Developmental Syndromes. ENDOCRINE INVOLVEMENT IN DEVELOPMENTAL SYNDROMES , 14 95 - 113.

Kapur, A; Hall, RJ; Qureshi, AC; Malik, IS; Flather, M; Roughton, M; Beatt, KJ; (2009) COMPARISON OF BARE METAL STENTS VERSUS DRUG-ELUTING STENTS IN PATIENTS WITH MULTIVESSEL DISEASE AND DIABETES: RESULTS FROM A CARDIA TRIAL SUBSTUDY. In: HEART. (pp. A7 - A8). B M J PUBLISHING GROUP

Kaput, J; Cotton, RG; Hardman, L; Watson, M; Al Aqeel, AI; Al-Aama, JY; Al-Mulla, F; (2009) Planning the human variome project: the Spain report. pp. 496-510.

Kaput, J; Cotton, RGH; Hardman, L; Watson, M; Al Aqeel, AI; Al-Aama, JY; Al-Mulla, F; (2009) Planning the Human Variome Project: The Spain Report. HUM MUTAT , 30 (4) 496 - 510. 10.1002/humu.20972.

Kashima, TG; Halai, DD; Tirabosco, R; Hing, S; Ye, H; Flanagan, AM; (2009) An Audit of Lipomatous Neoplasms: Correlation with MDM2 Amplification by Fluorescence In Situ Hybridisation. In: (Proceedings) 98th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology. (pp. 15A-15A). NATURE PUBLISHING GROUP

Kashima, TG; Halai, DD; Tirabosco, R; Hing, S; Ye, H; Flanagan, AM; (2009) An Audit of Lipomatous Neoplasms: Correlation with MDM2 Amplification by Fluorescence In Situ Hybridisation. In: (Proceedings) 98th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology. (pp. 15A-15A). NATURE PUBLISHING GROUP

Kayes, O; Loddo, M; Ambler, G; Stoeber, K; Williams, GH; Ralph, DJ; Minhas, S; (2009) DNA REPLICATION LICENSING FACTORS AND ANEUPLOIDY ARE LINKED TO TUMOUR CELL CYCLE STATES AND CLINICAL OUTCOME IN PENILE CARCINOMA. EUR UROL SUPPL , 8 (4) 368 - 368.

Kayes, O; Loddo, M; Ambler, G; Stoeber, K; Williams, GH; Ralph, DJ; Minhas, S; (2009) DNA replication licensing factors and aneuploidy are linked to tumour cell cycle states and clinical outcome in penile carcinoma. In: (Proceedings) 24th Annual EAU Congress. (pp. p. 368). Elsevier

Kayes, OJ; Loddo, M; Patel, N; Patel, P; Minhas, S; Ambler, G; Freeman, A; (2009) DNA Replication Licensing Factors and Aneuploidy Are Linked to Tumor Cell Cycle State and Clinical Outcome in Penile Carcinoma. CLIN CANCER RES , 15 (23) 7335 - 7344. 10.1158/1078-0432.CCR-09-0882.

Keenan, NG; Grasso, A; Locca, D; Varghese, A; Roughton, M; Gatehouse, PD; Firmin, DN; (2009) Comparison of 2D and multislab 3D magnetic resonance techniques for measuring carotid wall volumes (vol 28, pg 1476, 2008). J MAGN RESON IMAGING , 29 (6) 1493 - 1493. 10.1002/jmri.21771.

Keenan, NG; Locca, D; Varghese, A; Roughton, M; Gatehouse, PD; Hooper, J; Firmin, DN; (2009) Magnetic resonance of carotid artery ageing in healthy subjects. ATHEROSCLEROSIS , 205 (1) 168 - 173. 10.1016/j.atherosclerosis.2008.11.018.

Keenan, NG; Mason, JC; Maceira, A; Assomull, R; O'Hanlon, R; Chan, C; Roughton, M; (2009) Integrated Cardiac and Vascular Assessment in Takayasu Arteritis by Cardiovascular Magnetic Resonance. ARTHRITIS RHEUM , 60 (11) 3501 - 3509. 10.1002/art.24911.

Kelleher, MT; Fruhwirth, G; Patel, G; Ofo, E; Festy, F; Barber, PR; Ameer-Beg, SM; (2009) The potential of optical proteomic technologies to individualize prognosis and guide rational treatment for cancer patients. Target Oncol , 4 (3) pp. 235-252. 10.1007/s11523-009-0116-y.

Ketchell, RI; Roughton, M; Agent, P; Gyi, K; Hodson, ME; (2009) Predicting survival in end-stage cystic fibrosis. RESP MED , 103 (10) 1441 - 1447. 10.1016/j.rmed.2009.04.025.

Khorashad, JS; Wagner, S; Greener, L; Marin, D; Reid, A; Milojkovic, D; Patel, H; (2009) The level of BCR-ABL1 kinase activity before treatment does not identify chronic myeloid leukemia patients who fail to achieve a complete cytogenetic response on imatinib. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL , 94 (6) pp. 861-864. 10.3324/haematol.2008.003715.

Kim, BS; Miyagawa, F; Cho, Y-H; Bennett, CL; Clausen, BE; Katz, SI; (2009) Keratinocytes Function as Accessory Cells for Presentation of Endogenous Antigen Expressed in the Epidermis. JOURNAL OF INVESTIGATIVE DERMATOLOGY , 129 (12) pp. 2805-2817. 10.1038/jid.2009.176.

Kimpfler, S; Sevko, A; Ring, S; Falk, C; Osen, W; Frank, K; Kato, M; (2009) Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs. J Immunol , 183 (10) pp. 6330-6337. 10.4049/jimmunol.0900609.

Kirk, P; Roughton, M; Porter, JB; Walker, JM; Tanner, MA; Patel, J; Wu, D; (2009) Cardiac T2* magnetic resonance for prediction of cardiac complications in Thalassemia Major. Circulation , 120 (20) pp. 1961-1968. 10.1161/CIRCULATIONAHA.109.874487.

Kirk, P; Roughton, M; Porter, JB; Walker, JM; Tanner, MA; Patel, J; Wu, D; (2009) Cardiac T2*Magnetic Resonance for Prediction of Cardiac Complications in Thalassemia Major. CIRCULATION , 120 (20) 1961 - U23. 10.1161/CIRCULATIONAHA.109.874487.

Kirwan, M; Beswick, R; Vulliamy, T; Nathwani, AC; Walne, AJ; Casimir, C; Dokal, I; (2009) Exogenous TERC alone can enhance proliferative potential, telomerase activity and telomere length in lymphocytes from dyskeratosis congenita patients. BRIT J HAEMATOL , 144 (5) 771 - 781. 10.1111/j.1365-2141.2008.07516.x.

Kishnani, PS; DiRocco, M; Kaplan, P; Mehta, A; Pastores, GM; Smith, SE; Puga, AC; (2009) A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1. Molecular genetics and metabolism 10.1016/j.ymgme.2008.12.015.

Kitoh, A; Ono, M; Naoe, Y; Ohkura, N; Yamaguchi, T; Yaguchi, H; Kitabayashi, I; (2009) Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells. Immunity , 31 (4) pp. 609-620. 10.1016/j.immuni.2009.09.003.

Klanrit, P; Taebunpakul, P; Flinterman, MB; Odell, EW; Riaz, MA; Melino, G; Salomoni, P; (2009) PML involvement in the p73-mediated E1A-induced suppression of EGFR and induction of apoptosis in head and neck cancers. ONCOGENE , 28 (39) 3499 - 3512. 10.1038/onc.2009.191.

Knight, A; Mackinnon, S; Lowdell, MW; (2009) CMV-Reactive Gamma/Delta T Cells Expanded From CMV Seronegative Normal Healthy Individuals Lyse CMV-Infected Targets - Potential Adoptive Immunotherapy for Recipients of Stem Cell Transplants From CMV Seronegative Donors. In: BLOOD. (pp. 880 - 880). AMER SOC HEMATOLOGY

Knight, SJL; Akha, ES; Timbs, A; Enver, T; Pettitt, AR; Taylor, J; Hatton, CS; (2009) Identification of Novel Recurrent Copy Number Variations and Regions of Copy-Neutral Loss of Heterozygosity by High Resolution Genomic Array in Pre-Treatment and Relapsed B-CLL. In: (Proceedings) 51st Annual Meeting of the American-Society-of-Hematology. (pp. p. 451). AMER SOC HEMATOLOGY

Kocjan, G; Chandra, A; Cross, P; Denton, K; Giles, T; Herbert, A; Smith, P; (2009) BSCC Code of Practice - fine needle aspiration cytology. CYTOPATHOLOGY , 20 (5) 283 - 296. 10.1111/j.1365-2303.2009.00709.x.

Kocjan, G; Ramsay, A; Beale, T; O'Flynn, P; (2009) Head and neck cancer in the UK: what is expected of cytopathology? CYTOPATHOLOGY , 20 (2) 69 - 77. 10.1111/j.1365-2303.2009.00647.x.

Kok, K; Geering, B; Vanhaesebroeck, B; (2009) Regulation of phosphoinositide 3-kinase expression in health and disease. Trends Biochem Sci , 34 (3) pp. 115-127. 10.1016/j.tibs.2009.01.003.

Kok, K; Nock, GE; Verrall, EA; Mitchell, MP; Hommes, DW; Peppelenbosch, MP; Vanhaesebroeck, B; (2009) Regulation of p110δ PI 3-Kinase Gene Expression. PLoS One , 4 (4) , Article e5145. 10.1371/journal.pone.0005145. Green open access
file

Kolman, P; Pica, A; Carvou, N; Boyde, A; Cockcroft, S; Loesch, A; Pizzey, A; (2009) Insulin uptake across the luminal membrane of the rat proximal tubule in vivo and in vitro. AM J PHYSIOL-RENAL , 296 (5) F1227 - F1237. 10.1152/ajprenal.90351.2008.

Kranc, KR; Schepers, H; Rodrigues, NP; Bamforth, S; Villadsen, E; Ferry, H; Bouriez-Jones, T; (2009) Cited2 Is an Essential Regulator of Adult Hematopoietic Stem Cells. CELL STEM CELL , 5 (6) pp. 659-665. 10.1016/j.stem.2009.11.001.

Krishnamurthy, S; Shaw, BE; Byrne, J; Seedhouse, C; Mayor, N; Madrigal, JA; Russell, N; (2009) A caspase8 promoter polymorphism is associated with increased TRM and reduced survival following T-cell depleted unrelated donor transplantation using alemtuzumab. In: BONE MARROW TRANSPLANTATION. (pp. S79 - S80). NATURE PUBLISHING GROUP

Kristeleit, R; Calvert, H; Arkenau, H; Olmos, D; Adam, J; Plummer, ER; Lock, V; (2009) A phase I study of AT9283, an aurora kinase inhibitor, in patients with refractory solid tumors. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. ? - ?). AMER SOC CLINICAL ONCOLOGY

Kristeleit, R; O'Brien, M; (2009) Cardiotoxicity from cytotoxics in the 21st century. British Journal of Cardiology , 16 (2) pp. 60-62.

Kulkarni, AA; Kingsbury, SR; Tudzarova, S; Hong, HK; Loddo, M; Rashid, M; Rodriguez-Acebes, S; (2009) Cdc7 Kinase Is a Predictor of Survival and a Novel Therapeutic Target in Epithelial Ovarian Carcinoma. CLIN CANCER RES , 15 (7) 2417 - 2425. 10.1158/1078-0432.CCR-08-1276.

Kummar, S; Doroshow, JH; Tomaszewski, JE; Calvert, AH; Lobbezoo, M; Giaccone, G; Task Force MDICT, ; (2009) Phase 0 clinical trials: Recommendations from the task force on methodology for the development of innovative cancer therapies. EUR J CANCER , 45 (5) 741 - 746. 10.1016/j.ejca.2008.10.024.

Kwiatkowski, JL; Kim, HY; Thompson, AA; Quinn, CT; Mueller, BU; Odame, I; Giardina, PJ; (2009) Chelation Choices and Iron Burden Among Patients with Thalassemia in the 21st Century: a Report From the Thalassemia Clinical Research Network (TCRN) Longitudinal Cohort. In: BLOOD. (pp. 1555 - 1556). AMER SOC HEMATOLOGY

Kyriakou, C; Canals, C; Finke, J; Kobbe, G; Harousseau, J-L; Kolb, H-J; Novitzky, N; (2009) Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation. J Clin Oncol , 27 (24) pp. 3951-3958. 10.1200/JCO.2008.20.4628.

L

Lacombe, T; García-Gómez, JJ; de la Cruz, J; Roser, D; Hurt, E; Linder, P; Kressler, D; (2009) Linear ubiquitin fusion to Rps31 and its subsequent cleavage are required for the efficient production and functional integrity of 40S ribosomal subunits. Mol Microbiol , 72 (1) pp. 69-84. 10.1111/j.1365-2958.2009.06622.x.

Lajiness, J; Sielaff, A; MacKay, H; Brown, T; Kluza, J; Nguyen, B; Wilson, WD; (2009) Polyamide Curvature and DNA Sequence Selective Recognition: Use of 4-Aminobenzamide to Adjust Curvature. MED CHEM , 5 (3) 216 - 226.

Lambert, J; Linch, DC; Gale, RE; (2009) MULTIPLE JAK2 V617F MUTATIONS ARE PRESENT IN MOST PATIENTS WITH ESSENTIAL THROMBOCYTHAEMIA: A NEW DISEASE PARADIGM. In: HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. (pp. 421 - 421). FERRATA STORTI FOUNDATION Gold open access

Lambert, JR; Everington, T; Linch, DC; Gale, RE; (2009) In essential thrombocythemia, multiple JAK2-V617F clones are present in most mutant-positive patients: a new disease paradigm. BLOOD , 114 (14) 3018 - 3023. 10.1182/blood-2009-03-209916.

Lambert, JR; Gale, RE; Linch, DC; (2009) The production of JAK2 wild-type platelets is not downregulated in patients with JAK2 V617F mutant-positive essential thrombocythaemia. BRIT J HAEMATOL , 145 (1) 128 - 130. 10.1111/j.1365-2141.2009.07597.x.

Larkin, JMG; Kipps, ELS; Powell, CJ; Swanton, C; (2009) Systemic therapy for advanced renal cell carcinoma. Ther Adv Med Oncol , 1 (1) pp. 15-27. 10.1177/1758834009338430.

Lau-Walker, MO; Cowie, MR; Roughton, M; (2009) Coronary heart disease patients' perception of their symptoms and sense of control are associated with their quality of life three years following hospital discharge. J CLIN NURS , 18 (1) 63 - 71. 10.1111/j.1365-2702.2008.02386.x.

Lawrenson, K; Benjamin, E; Turmaine, M; Jacobs, I; Gayther, S; Dafou, D; (2009) In vitro three-dimensional modelling of human ovarian surface epithelial cells. CELL PROLIFERAT , 42 (3) 385 - 393. 10.1111/j.1365-2184.2009.00604.x.

Lawrie, AS; Albanyan, A; Cardigan, RA; Mackie, IJ; Harrison, P; (2009) Microparticle sizing by dynamic light scattering in fresh-frozen plasma. VOX SANG , 96 (3) 206 - 212. 10.1111/j.1423-0410.2008.01151.x.

Leclerc, X; Danos, O; Scherman, D; Kichler, A; (2009) A comparison of synthetic oligodeoxynucleotides, DNA fragments and AAV-1 for targeted episomal and chromosomal gene repair. BMC Biotechnol , 9 35-. 10.1186/1472-6750-9-35.

Ledermann, JA; Rustin, GJ; Hackshaw, A; Kaye, SB; Jayson, G; Gabra, H; James, LE; (2009) A randomized phase II placebo-controlled trial using maintenance therapy to evaluate the vascular targeting agent BIBF 1120 following treatment of relapsed ovarian cancer (OC). In: JOURNAL OF CLINICAL ONCOLOGY. (pp. ? - ?). AMER SOC CLINICAL ONCOLOGY

Ledermann, JA; Rustin, GJ; Hackshaw, A; Kaye, SB; Jayson, G; Gabra, H; James, LE; (2009) A randomized phase II placebo-controlled trial using maintenance therapy to evaluate the vascular targeting agent BIBF 1120 following treatment of relapsed ovarian cancer (OC). J Clin Oncol , 27 (15_suppl) 5501-.

Ledermann, JA; Stebbing, J; (2009) Positioning pemetrexed in the treatment of ovarian cancer. EUR J CANCER , 45 (8) 1330 - 1332. 10.1016/j.ejca.2009.02.006.

Lee, AJX; Kolesnick, R; Swanton, C; (2009) RNAi-mediated functional analysis of pathways influencing cancer cell drug resistance. Expert Rev Mol Med , 11 , Article e15. 10.1017/S1462399409001070.

Lee, CA; Chi, C; Shiltagh, N; Pollard, D; Griffioen, A; Dunn, N; Kadir, RA; (2009) Review of a multidisciplinary clinic for women with inherited bleeding disorders. HAEMOPHILIA , 15 (1) 359 - 360. 10.1111/j.1365-2516.2008.01824.x.

Lee, SM; Hackshaw, A; (2009) Correspondence. Response: Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomised, double-blind, placebo-controlled trial. Journal of the National Cancer Institute

Lee, SM; James, LE; Qian, W; Spiro, S; Eisen, T; Gower, NH; Ferry, DR; (2009) Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer. THORAX , 64 (1) pp. 75-80. 10.1136/thx.2007.093872.

Lee, SM; Rudd, R; Woll, PJ; Ottensmeier, C; Gilligan, D; Price, A; Spiro, S; (2009) Randomized double-blind placebo-controlled trial of thalidomide in combination with gemcitabine and Carboplatin in advanced non-small-cell lung cancer. J Clin Oncol , 27 (31) pp. 5248-5254. 10.1200/JCO.2009.21.9733.

Lee, SM; Rudd, R; Woll, PJ; Ottensmeier, C; Gilligan, D; Price, A; Spiro, S; (2009) Randomized double-blind placebo-controlled trial of thalidomide in combination with gemcitabine and carboplatin in advanced non-small-cell lung cancer. Journal of Clinical Oncology , 27 (31) pp. 5248-5254. 10.1200/JCO.2009.21.9733.

Lee, SM; Woll, PJ; Rudd, R; Ferry, D; O'Brien, M; Middleton, G; Spiro, S; (2009) Anti-angiogenic therapy using thalidomide combined with chemotherapy in small cell lung cancer: a randomized, double-blind, placebo-controlled trial. J Natl Cancer Inst , 101 (15) pp. 1049-1057. 10.1093/jnci/djp200. Green open access

Leedham, SJ; Graham, TA; Oukrif, D; McDonald, SAC; Rodriguez-Justo, M; Harrison, RF; Shepherd, NA; (2009) Clonality, Founder Mutations, and Field Cancerization in Human Ulcerative Colitis-Associated Neoplasia. GASTROENTEROLOGY , 136 (2) 542 - 550. 10.1053/j.gastro.2008.10.086.

Leitner, S; Sweeney, K; Oberg, D; Davies, D; Miranda, E; Lemoine, NR; Hallden, G; (2009) Oncolytic Adenoviral Mutants with E1B19K Gene Deletions Enhance Gemcitabine-induced Apoptosis in Pancreatic Carcinoma Cells and Anti-Tumor Efficacy In vivo. Clinical Cancer Research , 15 (5) pp. 1730-1740. 10.1158/1078-0432.CCR-08-2008.

Lhériteau, E; Libeau, L; Stieger, K; Deschamps, J-Y; Mendes-Madeira, A; Provost, N; Lemoine, F; (2009) The RPGRIP1-deficient dog, a promising canine model for gene therapy. Mol Vis , 15 pp. 349-361.

Li, W; Ferguson, BJ; Khaled, WT; Tevendale, M; Stingl, J; Poli, V; Rich, T; (2009) PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool. P NATL ACAD SCI USA , 106 (12) 4725 - 4730. 10.1073/pnas.0807640106.

Liu, D; Zhang, T; Marshall, AJ; Okkenhaug, K; Vanhaesebroeck, B; Uzonna, JE; (2009) The p110delta isoform of phosphatidylinositol 3-kinase controls susceptibility to Leishmania major by regulating expansion and tissue homing of regulatory T cells. J Immunol , 183 (3) pp. 1921-1933. 10.4049/jimmunol.0901099.

Liu, ML; Liu, MJ; Shen, YF; Ryu, H; Kim, HJ; Klupsch, K; Downward, J; (2009) Omi is a mammalian heat-shock protein that selectively binds and detoxifies oligomeric amyloid-beta. J CELL SCI , 122 (11) 1917 - 1926. 10.1242/jcs.042226.

Loddo, M; Kingsbur, SR; Rashid, M; Proctor, I; Holt, C; Young, J; El Sheikh, S; (2009) Cell cycle phase progression analysis identifies unique replication phenotypes of major prognostic and predictive significance in cancer. In: CANCER RESEARCH. (pp. 320S - 320S). AMER ASSOC CANCER RESEARCH

Loddo, M; Kingsbury, SR; Rashid, M; Proctor, I; Holt, C; Young, J; El-Sheikh, S; (2009) Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancer. BRIT J CANCER , 100 (6) 959 - 970. 10.1038/sj.bjc.6604924.

Lolkema, MP; Harrington, K; Evans, J; Arkenau, HT; Roxburgh, P; Morrison, R; Roulstone, V; (2009) A phase-I study of the combination of intravenous reovirus (REOLYSIN (R)) and gemcitabine in patients with advanced cancer. In: (pp. p. 131).

Loong, SLE; Hwang, JSG; Li, HH; Wee, JTS; Yap, SP; Chua, MLK; Fong, KW; (2009) Weak expression of cyclooxygenase-2 is associated with poorer outcome in endemic nasopharyngeal carcinoma: analysis of data from randomized trial between radiation alone versus concurrent chemo-radiation (SQNP-01). RADIAT ONCOL , 4 , Article 23. 10.1186/1748-717X-4-23.

Lopez, MN; Pereda, C; Segal, G; Munoz, L; Aguilera, R; Gonzalez, FE; Escobar, A; (2009) Prolonged Survival of Dendritic Cell-Vaccinated Melanoma Patients Correlates With Tumor-Specific Delayed Type IV Hypersensitivity Response and Reduction of Tumor Growth Factor beta-Expressing T Cells. J CLIN ONCOL , 27 (6) 945 - 952. 10.1200/JCO.2008.18.0794.

Lorenz, A; Osman, F; Folkyte, V; Sofueva, S; Whitby, MC; (2009) Fbh1 Limits Rad51-Dependent Recombination at Blocked Replication Forks. MOL CELL BIOL , 29 (17) 4742 - 4756. 10.1128/MCB.00471-09.

Lowdell, MW; Morris, E; (2009) Recent advances in clinical cellular immunotherapy. In: Practical Transfusion Medicine: Third Edition. (pp. 462-468).

Lowe, HL; Sharma, SK; Bagshawe, KD; Chester, KA; (2009) Antibody directed enzyme prodrug therapy (ADEPT). In: Recombinant Antibodies for Immunotherapy. (pp. 336-349).

Lugli, E; Ferraresi, R; Roat, E; Troiano, L; Pinti, M; Nasi, M; Nemes, E; (2009) Quercetin inhibits lymphocyte activation and proliferation without inducing apoptosis in peripheral mononuclear cells. LEUKEMIA RES , 33 (1) 140 - 150. 10.1016/j.leukres.2008.07.025.

M

Mackall, C; Fry, T; Gress, R; Peggs, K; Storek, J; Toubert, A; (2009) Background to hematopoietic cell transplantation, including post transplant immune recovery. BONE MARROW TRANSPL , 44 (8) 457 - 462. 10.1038/bmt.2009.255.

Mackenzie, GD; Dunn, JM; Selvasekar, CR; Mosse, CA; Thorpe, SM; Novelli, MR; Bown, SG; (2009) Optimal conditions for successful ablation of high-grade dysplasia in Barrett's oesophagus using aminolaevulinic acid photodynamic therapy. LASER MED SCI , 24 (5) 729 - 734. 10.1007/s10103-008-0630-7.

Mahendran, AO; Elvey, M; Howie, AJ; Dupont, P; Veitch, PS; (2009) Early Renal Transplant Protocol Biopsies Directly Influence Patient Management. In: (Proceedings) 9th Joint Meeting of the American-Society-of-Transplant-Surgeon/American-Society-of-Transplantation. (pp. p. 213). WILEY-BLACKWELL PUBLISHING, INC

Mahendran, AO; Elvey, M; Mahendran, M; Howie, AJ; Dupont, P; Veitch, PS; (2009) EARLY RENAL TRANSPLANT PROTOCOL BIOPSIES DIRECTLY INFLUENCE PATIENT MANAGEMENT. TRANSPLANT INTERNATIONAL , 22 p. 16.

Mahendran, AO; Haroon, S; Dupont, PJ; Howie, A; Veitch, PS; (2009) AN INCREMENTAL INCREASE IN CHRONIC ALLOGRAFT DAMAGE DETECTED ON PROTOCOL BIOPSIES DURING THE FIRST YEAR POST-TRANSPLANTATION. TRANSPL INT , 22 260 - 260.

Makrogianneli, K; Carlin, LM; Keppler, MD; Matthews, DR; Ofo, E; Coolen, A; Ameer-Beg, SM; (2009) Integrating Receptor Signal Inputs That Influence Small Rho GTPase Activation Dynamics at the Immunological Synapse. Molecular and Cellular Biology , 29 (11) pp. 2997-3006. 10.1128/MCB.01008-08.

Malladi, R; Sloane-Stanley, J; Gupta, R; Rodrigues, N; Wood, W; Enver, T; (2009) THE EFFECT OF THE TEL-TRKC ONCOGENE ON THE HAEMATO-ENDOTHELIAL DIFFERENTIATION FROM HUMAN EMBRYONIC STEM CELLS. In: (Proceedings) 14th Annual Meeting of the European-Hematology-Association. (pp. p. 2). FERRATA STORTI FOUNDATION Gold open access

Mamopoulos, AM; Hughes, DA; Tuck, SMMAB; (2009) Gaucher disease and pregnancy. Journal of Obstetrics and Gynaecology , 29 (3) pp. 240-251. 10.1080/01443610902754398.

Maniaci, V; Davidson, BR; Rolles, K; Dhillon, AP; Hackshaw, A; Begent, RH; Meyer, T; (2009) Fibrolamellar hepatocellular carcinoma - Prolonged survival with multimodality therapy. EJSO-EUR J SURG ONC , 35 (6) 617 - 621. 10.1016/j.ejso.2008.12.009.

Manousou, P; Arvaniti, V; Tsochatzis, E; Germani, G; Rolando, N; Pleguezuelo, M; Jones, K; (2009) RECURRENCE PRIMARY BILIARY CIRRHOSIS AFTER LIVER TRANSPLANTATION: THE EFFECT OF AZATHIOPRINE. In: JOURNAL OF HEPATOLOGY. (pp. S180 - S180). ELSEVIER SCIENCE BV

Manousou, P; Burroughs, AK; Isgro, G; Calvaruso, V; Luong, TV; Tsochatzis, E; Kalambokis, G; (2009) COMPUTER-ASSISTED IMAGE ANALYSIS OF LIVER COLLAGEN AT ONE YEAR BIOPSY CAN PREDICT CLINICAL OUTCOME IN HCV POST LT PATIENTS. In: HEPATOLOGY. (pp. 302A - 303A). JOHN WILEY & SONS INC

Manousou, P; Samonakis, D; Cholongitas, E; Patch, D; O'Beirne, J; Dhillon, AP; Rolles, K; (2009) Outcome of Recurrent Hepatitis C Virus After Liver Transplantation in a Randomized Trial of Tacrolimus Monotherapy Versus Triple Therapy. LIVER TRANSPLANT , 15 (12) 1783 - 1791. 10.1002/lt.21907.

Mansour, MR; (2009) Oncogenic Kras and Notch-1 cooperate in T-cell acute lymphoblastic leukemia/lymphoma. EXPERT REVIEW OF HEMATOLOGY , 2 (2) pp. 133-136. 10.1586/EHM.09.3.

Mansour, MR; Sulis, ML; Duke, V; Foroni, L; Jenkinson, S; Koo, K; Allen, CG; (2009) Prognostic Implications of NOTCH1 and FBXW7 Mutations in Adults With T-Cell Acute Lymphoblastic Leukemia Treated on the MRC UKALLXII/ECOG E2993 Protocol. J CLIN ONCOL , 27 (26) 4352 - 4356. 10.1200/JCO.2009.22.0996.

Mantovani, J; Charrier, S; Eckenberg, R; Saurin, W; Danos, O; Perea, J; Galy, A; (2009) Diverse genomic integration of a lentiviral vector developed for the treatment of Wiskott-Aldrich syndrome. J Gene Med , 11 (8) pp. 645-654. 10.1002/jgm.1346.

Manzano, L; Babalis, DS; Roughton, M; Shibata, MC; Anker, SD; Ghio, S; Poole-Wilson, PA; (2009) Predictors of Clinical Outcomes in Elderly Patients With Chronic Heart Failure: Results From the SENIORS Sstudy. In: CIRCULATION. (pp. S534 - S534). LIPPINCOTT WILLIAMS & WILKINS

Marelli, L; Shusang, V; Buscombe, JR; Cholongitas, E; Stigliano, R; Davies, N; Tibballs, J; (2009) Transarterial Injection of I-131-Lipiodol, Compared with Chemoembolization, in the Treatment of Unresectable Hepatocellular Cancer. JOURNAL OF NUCLEAR MEDICINE , 50 (6) pp. 871-877. 10.2967/jnumed.108.060558.

Marina, N; Bielack, S; Whelan, J; Smeland, S; Krailo, M; Sydes, MR; Butterfass-Bahloul, T; (2009) International Collaboration is Feasible in Trials for Rare Conditions: The EURAMOS Experience. PEDIATRIC AND ADOLESCENT OSTEOSARCOMA , 152 339 - 353.

Marks, DI; Paietta, EM; Moorman, AV; Richards, SM; Buck, G; DeWald, G; Ferrando, A; (2009) T-cell acute lymphoblastic leukemia in adults: clinical features, immunophenotype, cytogenetics, and outcome from the large randomized prospective trial (UKALL XII/ECOG 2993). BLOOD , 114 (25) 5136 - 5145. 10.1182/blood-2009-08-231217.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update April 2009. TISSUE ANTIGENS , 74 (3) pp. 272-275. 10.1111/j.1399-0039.2009.01322.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update August 2008. TISSUE ANTIGENS , 73 (1) pp. 91-92. 10.1111/j.1399-0039.2008.01165.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update December 2008. TISSUE ANTIGENS , 73 (6) pp. 629-631. 10.1111/j.1399-0039.2009.01242.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update February 2009. TISSUE ANTIGENS , 74 (2) pp. 180-182. 10.1111/j.1399-0039.2009.01285.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update January 2009. TISSUE ANTIGENS , 74 (2) pp. 177-179. 10.1111/j.1399-0039.2009.01284.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update July 2008. TISSUE ANTIGENS , 73 (1) pp. 88-90. 10.1111/j.1399-0039.2008.01164.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update June 2009. TISSUE ANTIGENS , 74 (4) pp. 364-366. 10.1111/j.1399-0039.2009.01330.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update March 2009. TISSUE ANTIGENS , 74 (2) pp. 183-186. 10.1111/j.1399-0039.2009.01288.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update May 2009. TISSUE ANTIGENS , 74 (4) pp. 358-363. 10.1111/j.1399-0039.2009.01321.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update November 2008. TISSUE ANTIGENS , 73 (4) pp. 383-384. 10.1111/j.1399-0039.2009.01212.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update October 2008. TISSUE ANTIGENS , 73 (4) pp. 381-382. 10.1111/j.1399-0039.2009.01211.x.

Marsh, SGE; (2009) Nomenclature for factors of the HLA system, update September 2008. TISSUE ANTIGENS , 73 (1) pp. 93-94. 10.1111/j.1399-0039.2008.01169.x.

Marthandan, N; Karp, DR; Amett, F; Waller, MJ; Guidry, P; Feolo, M; Marsh, SGE; (2009) HLA genetic association analysis using the sequence feature variant type approach. JOURNAL OF IMMUNOLOGY , 182

Martín Caballero, I; Hansen, J; Leaford, D; Pollard, S; Hendrich, BD; (2009) The methyl-CpG binding proteins Mecp2, Mbd2 and Kaiso are dispensable for mouse embryogenesis, but play a redundant function in neural differentiation. PLoS One , 4 (1) , Article e4315. 10.1371/journal.pone.0004315. Green open access
file

Masir, N; Campbell, LJ; Goff, LK; Jones, M; Marafioti, T; Cordell, J; Clear, AJ; (2009) BCL2 protein expression in follicular lymphomas with t(14;18) chromosomal translocations. Br J Haematol , 144 (5) pp. 716-725. 10.1111/j.1365-2141.2008.07528.x.

Mattar, CN; Dighe, NM; Waddington, SN; McIntosh, J; Biswas, A; Fisk, NM; Davidoff, AM; (2009) Long-Term Transgene Expression in New-Born Cynomolgus Macaques Following Intra-Uterine Gene Transfer of Self-Complementary AAV. In: MOLECULAR THERAPY. (pp. S117 - S117). NATURE PUBLISHING GROUP

Mayor, N; Shaw, BE; Cooke, L; Marsh, S; Madrigal, JA; (2009) The impact of NOD2/CARD15 SNP 5 on the outcome of unrelated donor haematopoietic stem cell transplantation for acute lymphoblastic leukaemia. In: BONE MARROW TRANSPLANTATION. (pp. S203 - S203). NATURE PUBLISHING GROUP

Mayor, NP; Shaw, BE; Cooke, L; Madrigal, JA; Marsh, SGE; (2009) Predicting disease relapse using NOD2/CARD15 SNP5 and HLA-DPB1 matching status. INT J IMMUNOGENET , 36 (5) 317 - 318.

Mayor, NP; Shaw, BE; Cooke, L; Madrigal, JA; Marsh, SGE; (2009) The impact of NOD2/CARD15 SNP 5 on the outcome of unrelated donor hematopoietic stem cell transplantation for acute lymphoblastic leukaemia. In: TISSUE ANTIGENS. (pp. 403 - 403). WILEY-BLACKWELL PUBLISHING, INC

McCabe, DJH; Starke, R; Harrison, P; Brown, MM; Sidhu, PS; Mackie, IJ; Machin, SJ; (2009) ADAMTS-13 (VON WILLEBRAND FACTOR-CLEAVING PROTEASE) ACTIVITY IN THE EARLY AND LATE PHASES AFTER TRANSIENT ISCHAEMIC ATTACK OR ISCHAEMIC STROKE. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 103 - 104). B M J PUBLISHING GROUP

McCabe, N; Cerone, MA; Ohishi, T; Seimiya, H; Lord, CJ; Ashworth, A; (2009) Targeting Tankyrase 1 as a therapeutic strategy for BRCA-associated cancer. Oncogene , 28 (11) pp. 1465-1470. 10.1038/onc.2008.483.

McClelland, B; Cohen, H; McClelland, B; (2009) Risks of transfusion in the context of haemovigilance: SHOT - the UK haemovigilance system. In: ABC of transfusion medicine: british medical journal books. (pp. 83-88). Wiley-Blackwell

McClelland, SE; Burrell, RA; Swanton, C; (2009) Chromosomal instability: a composite phenotype that influences sensitivity to chemotherapy. Cell Cycle , 8 (20) pp. 3262-3266. 10.4161/cc.8.20.9690.

McCormack, M; Ledermann, J; Hall-Craggs, M; Symonds, P; Warwick, V; Fernando, I; Hackshaw, A; (2009) Phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer. In: (Proceedings) ASCO. (pp. A5586-).

McCormack, M; Ledermann, JA; Hall-Craggs, MA; Symonds, RP; Warwick, V; Simonds, H; Fernando, I; (2009) A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. ? - ?). AMER SOC CLINICAL ONCOLOGY

McCormack, M; Ledermann, JA; Hall-Craggs, MA; Symonds, RP; Warwick, V; Simonds, H; Fernando, I; (2009) A phase II study of weekly neoadjuvant chemotherapy followed by radical chemoradiation for locally advanced cervical cancer. J Clin Oncol , 27 (15_suppl) 5586-.

McDermott, AB; Cohen, SBA; Zuckerman, JN; Madrigal, JA; (2009) Hepatitis B third generation vaccines: improves response and conventional vaccine non-response - evidence for genetic basis in man. Journal of Viral Hepatitis , 5 pp. 9-11.

McDonald, V; Laffan, M; Benjamin, S; Bevan, D; Machin, S; Scully, MA; (2009) Thrombotic thrombocytopenic purpura precipitated by acute pancreatitis: a report of seven cases from a regional UK TTP registry. BRIT J HAEMATOL , 144 (3) 430 - 433. 10.1111/j.1365-2141.2008.07458.x.

McDonald, V; Leandro, M; (2009) Rituximab in non-haematological disorders of adults and its mode of action. BRIT J HAEMATOL , 146 (3) 233 - 246. 10.1111/j.1365-2141.2009.07718.x.

McDonald, V; Scully, M; Manns, K; Mackie, IJ; Machin, SJ; (2009) Serum rituximab levels in TTP: the effect of plasma exchange and correlation with response to treatment. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 5 - 5). WILEY-BLACKWELL PUBLISHING, INC

McGovern, UB; Francis, RE; Peck, B; Guest, SK; Wang, J; Myatt, SS; Krol, J; (2009) Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer. Mol Cancer Ther , 8 (3) pp. 582-591. 10.1158/1535-7163.MCT-08-0805.

McGovern, UB; Stebbing, J; (2009) Receptor-based predictors of response in breast cancer. [Editorial comment]. Future Oncology , 5 (3) 283 - 286. 10.2217/fon.09.1. Green open access
file

Mednick, L; Yu, SL; Trachtenberg, F; Kleinert, DA; Giardina, PJ; Kwiatkowski, JL; Foote, D; (2009) Symptoms of Anxiety and Depression Among Teens and Adults in the Thalassemia Longitudinal Cohort Study. In: BLOOD. (pp. 231 - 232). AMER SOC HEMATOLOGY

Mehta, A; (2009) Eighth International Symposium on Lysosomal Storage Diseases. International Journal of Clinical Pharmacology and Therapeutics , 47 (supp 1) S1-S3.

Mehta, A; (2009) Psychosocial aspects of Fabry disease and their impact on optimal disease management. Clinical Therapeutics , 31 s1-s2.

Mehta, A; Clarke, JTR; Giugliani, R; Elliott, P; Linhart, A; Beck, MS-PG; (2009) Natural course of Fabry disease: changing pattern of causes of death in FOS – Fabry Outcome Survery. Journal of Medical Genetics , 46 pp. 548-552. 10.1136/jmg.2008.065904.

Mehta, A; Hoffbrand, A; (2009) Haematology at a Glance. [Book]. (3rd ed.). Blackwell Wiley

Mehta, AB; (2009) Anderson – Fabry Disease : developments in diagnosis and therapy. International Journal of Clinical Pharmacology and Therapeutics , 47 (1) s66-s74.

Mehta, AB; (2009) Common hereditary lysosomal storage disorders. BMJ Point of Care

Meng, S; Arbit, T; Veeriah, S; Mellinghoff, IK; Fang, F; Vivanco, I; Rohle, D; (2009) 14-3-3sigma and p21 synergize to determine DNA damage response following Chk2 inhibition. Cell Cycle , 8 (14) pp. 2238-2246. 10.4161/cc.8.14.8998.

Meyer, T; (2009) Interventional Radiological Treatment of Liver Tumours. British Journal of Cancer , 100 p. 1975.

Meyer, T; Gaya, AM; Dancey, G; Stratford, MRL; Othman, S; Sharma, SK; Wellsted, D; (2009) A Phase I Trial of Radioimmunotherapy with I-131-A5B7 Anti-CEA Antibody in Combination with Combretastatin-A4-Phosphate in Advanced Gastrointestinal Carcinomas. CLIN CANCER RES , 15 (13) 4484 - 4492. 10.1158/1078-0432.CCR-09-0035.

Michelagnoli, M; Kotecha, K; Anazado, A; Flanagan, A; Tirabosco, R; Briggs, T; Cannon, S; (2009) OUTLOOK FOR CHILDREN UNDER 13 YEARS WITH PRIMARY MALIGNANT BONE TUMOURS - THE LONDON SARCOMA SERVICE EXPERIENCE 1999-2009. PEDIATR BLOOD CANCER , 53 (5) 797 - 798.

Middleton, D; Gonzalez, F; Fernandez-Vina, M; Tiercy, J-M; Marsh, SGE; Aubrey, M; Bicalho, MG; (2009) A bioinformatics approach to ascertaining the rarity of HLA alleles. TISSUE ANTIGENS , 74 (6) pp. 480-485. 10.1111/j.1399-0039.2009.01361.x.

Miene, C; Klenow, S; Veeriah, S; Richling, E; Glei, M; (2009) Impact of apple polyphenols on GSTT2 gene expression, subsequent protection of DNA and modulation of proliferation using LT97 human colon adenoma cells. Mol Nutr Food Res , 53 (10) pp. 1254-1262. 10.1002/mnfr.200800444.

Mikosch, P; Reed, M; Stettner, H; Baker, R; Mehta, ABHDA; (2009) Patients with Gaucher disease living in England show a high prevalence of vitamin D insufficiency with correlation to osteodensitrometry. Molecular genetics and metabolism

Miller, K; Ibrahim, M; Herriot, K; (2009) The UK NEQAS online auditing system for breast cancer predictive markers. VIRCHOWS ARCH , 455 75 - 75.

Mischerikow, N; Spedale, G; Altelaar, AFM; Timmers, HTM; Pijnappel, WWMP; Heck, AJR; (2009) In-depth profiling of post-translational modifications on the related transcription factor complexes TFIID and SAGA. J Proteome Res , 8 (11) pp. 5020-5030. 10.1021/pr900449e.

Mohamedbhai, SG; Lowry, L; Goldstone, AH; Linch, DC; Ardeshna, KM; (2009) Rituximab in combination with CODOX-M/IVAC: toxicity and efficacy in 17 adults with non-HIV related B-cell non-Hodgkin lymphomas with 495% proliferation index. In: BRITISH JOURNAL OF HAEMATOLOGY. (pp. 15 - 16). WILEY-BLACKWELL PUBLISHING, INC

Moilanen, P; Korppi, M; Hovi, L; Chapgier, A; Feinberg, J; Kong, X-F; Boisson-Dupuis, S; (2009) Successful hematopoietic stem cell transplantation from an unrelated donor in a child with interferon gamma receptor deficiency. Pediatr Infect Dis J , 28 (7) pp. 658-660. 10.1097/INF.0b013e318195092e.

Moisoi, N; Klupsch, K; Fedele, V; East, P; Sharma, S; Renton, A; Plun-Favreau, H; (2009) Mitochondrial dysfunction triggered by loss of HtrA2 results in the activation of a brain-specific transcriptional stress response. CELL DEATH DIFFER , 16 (3) 449 - 464. 10.1038/cdd.2008.166.

Moore, P; Barlis, P; Spiro, J; Ghimire, G; Roughton, M; Di Mario, C; Wallis, W; (2009) A Randomized Optical Coherence Tomography Study of Coronary Stent Strut Coverage and Luminal Protrusion With Rapamycin-Eluting Stents. JACC-CARDIOVASC INTE , 2 (5) 437 - 444. 10.1016/j.jcin.2009.01.010.

Morris, E; Thomson, KJ; (2009) Bone marrow and stem cell transplantation. Medicine , 37 (3) pp. 168-171.

Morris, JR; Boutell, C; Keppler, M; Densham, R; Weekes, D; Alamshah, A; Butler, L; (2009) The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. Nature , 462 (7275) pp. 886-890. 10.1038/nature08593.

Morris, T; Kettle, P; Drake, M; Quinn, M; Cavet, J; Tighe, J; Kazmi, M; (2009) Second Autologous Transplantation After Bortezomib-Based Re-induction Therapy: The UK Experience. CLINICAL LYMPHOMA & MYELOMA , 9 S40-S41.

Morris, T; Oakervee, H; Kettle, P; Drake, M; Brunton, A; Cook, G; Leahy, M; (2009) The PAD (Ireland) Study for Patients with Refractory and Relapsed Myeloma: An Update. CLINICAL LYMPHOMA & MYELOMA , 9 S27-S27.

Morris, TCM; Kettle, P; Drake, M; Brunton, A; Cook, G; Leahy, M; O'Dwyer, M; (2009) Bortezomib, adriamycin and dexamethasone for patients with refractory and relapsed myeloma - results from the PAD (Ireland) study. In: (Proceedings) 49th Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 16). WILEY-BLACKWELL PUBLISHING, INC

Morris, TCM; Kettle, P; Drake, M; Quinn, M; Cavet, J; Tighe, J; Kazmi, M; (2009) Good response rates following second autologous transplantation after bortezomib-based re-induction therapy. In: (Proceedings) 49th Annual Scientific Meeting of the British-Society-for-Haematology. (pp. p. 87). WILEY-BLACKWELL PUBLISHING, INC

Mulder, K; Westrate, L; Brown, T; Mackay, H; Chavda, S; Babu, B; Wilson, D; (2009) DNA sequence selective recognition by the pyrrole(H)/N-methylpyrrole and pyrrole(H)/N-methylimidazole: Design, synthesis, and biophysical characteristics. ABSTR PAP AM CHEM S , 238 ? - ?.

Murugaesu, N; Powles, T; Bestwick, J; Oliver, RTD; Shamash, J; (2009) Long-term follow-up of testicular cancer patients shows no predisposition to osteoporosis. Osteoporos Int , 20 (9) pp. 1627-1630. 10.1007/s00198-008-0793-x.

Mustapa, MFM; Grosse, SM; Kudsiova, L; Elbs, M; Raiber, EA; Wong, JB; Brain, APR; (2009) Stabilized Integrin-Targeting Ternary LPD (Lipopolyplex) Vectors for Gene Delivery Designed To Disassemble Within the Target Cell. BIOCONJUGATE CHEM , 20 (3) 518 - 532. 10.1021/bc800450r.

N

Nagao, K; Ginhoux, F; Leitner, WW; Motegi, S-I; Bennett, CL; Clausen, BE; Merad, M; (2009) Murine epidermal Langerhans cells and langerin-expressing dermal dendritic cells are unrelated and exhibit distinct functions. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , 106 (9) pp. 3312-3317. 10.1073/pnas.0807126106.

Nariculam, J; Freeman, A; Bott, S; Munson, P; Cable, N; Brookman-Amissah, N; Williamson, M; (2009) Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer: the expression of BCL-2, E-cadherin, Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for clinical and pathological risk factors. ASIAN J ANDROL , 11 (1) 109 - 118. 10.1038/aja.2008.22.

Nathwani, AC; Cochrane, M; McIntosh, J; Ng, CYC; Zhou, J; Gray, JT; Davidoff, AM; (2009) Enhancing transduction of the liver by adeno-associated viral vectors. GENE THER , 16 (1) 60 - 69. 10.1038/gt.2008.137.

Natkunam, Y; Tedoldi, S; Paterson, JC; Zhao, S; Rodriguez-Justo, M; Beck, AH; Siebert, R; (2009) Characterization of c-Maf transcription factor in normal and neoplastic hematolymphoid tissue and its relevance in plasma cell neoplasia. Am J Clin Pathol , 132 (3) pp. 361-371. 10.1309/AJCPEAGDKLWDMB1O.

Ng, T; Boguslavsky, SK; Tarcic, G; Wakim, J; Kiuchi, T; Liu, A; Reinitz, F; (2009) An Unbiased Screen Identifies DEP-1 Tumor Suppressor as a Phosphatase Controlling EGFR Endocytosis. Current Biology , 19 (21) pp. 1788-1798. 10.1016/j.cub.2009.09.048.

Nicol, ED; Stirrup, J; Roughton, M; Padley, SPG; Rubens, MB; (2009) 64-Channel Cardiac Computed Tomography: Intraobserver and Interobserver Variability (Part 1): Coronary Angiography. J COMPUT ASSIST TOMO , 33 (2) 161 - 168.

Nicol, ED; Stirrup, J; Roughton, M; Padley, SPG; Rubens, MB; (2009) 64-Channel Cardiac Computed Tomography: Intraobserver and Interobserver Variability, Part 2: Global and Regional Ventricular Function, Mass, and First Pass Perfusion. J COMPUT ASSIST TOMO , 33 (2) 169 - 174.

Nikitenko, LL; (2009) Vascular endothelium in cancer. CELL TISSUE RES , 335 (1) 223 - 240. 10.1007/s00441-008-0707-4.

Nimmo, RA; Slack, FJ; (2009) An elegant miRror: microRNAs in stem cells, developmental timing and cancer. CHROMOSOMA , 118 (4) pp. 405-418. 10.1007/s00412-009-0210-z.

Novakovic, B; Sibson, M; Ng, HK; Manuelpillai, U; Rakyan, V; Down, T; Beck, S; (2009) Placenta-specific methylation of the vitamin d 24-hydroxylase gene implications for feedback autoregulation of active vitamin d levels at the fetomaternal interface. The journal of biological chemistry , 284 (22) 14838 - 14848. 10.1074/jbc.M809542200. Green open access
file

Novakovic, B.; Sibson, M.; Ng, H.K.; Manuelpillai, U.; Rakyan, V.; Down, T.; Beck, S.; (2009) Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface. Journal of Biological Chemistry , 284 (22) pp. 14838-14848. 10.1074/jbc.M809542200. Green open access
file

O

O' Reilly, LA; Tai, L; Lee, L; Kruse, EA; Grabow, S; Fairlie, WD; Haynes, NM; (2009) Membrane-bound Fas ligand only is essential for Fas-induced apoptosis. Nature , 461 (7264) pp. 659-663. 10.1038/nature08402.

O'Donnell, G; Poeschl, R; Zimhony, O; Gunaratnam, M; Moreira, JBC; Neidle, S; Evangelopoulos, D; (2009) Bioactive Pyridine-N-oxide Disulfides from Allium stipitatum. JOURNAL OF NATURAL PRODUCTS , 72 (3) pp. 360-365. 10.1021/np800572r.

Observer, ; (2009) Smoking is a childhood addiction. Protect our children-vote to put tobacco out of sight.

Ogilvie, R; Plaunt, A; Riddering, C; Westrate, L; Davis, R; Ferguson, A; Chavda, S; (2009) ORGN 339-Design, synthesis and DNA binding properties of orthogonally positioned diamino-containing polyamides. ABSTR PAP AM CHEM S , 237 ? - ?.

Olmos, D; Arkenau, H-T; Ang, JE; Ledaki, I; Attard, G; Carden, CP; Reid, AHM; (2009) Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience. Ann Oncol , 20 (1) pp. 27-33. 10.1093/annonc/mdn544.

Ooi, SKT; O'Donnell, AH; Bestor, TH; (2009) Mammalian cytosine methylation at a glance. J CELL SCI , 122 (16) 2787 - 2791. 10.1242/jcs.015123.

Ors, A; Grimaldi, M; Kimata, Y; Wilkinson, CR; Jones, N; Yamano, H; (2009) The transcription factor Atf1 binds and activates the APC/C ubiquitin ligase in fission yeast. J. Biol. Chem. , 284 (36) pp. 23989-23994. Gold open access

Orti, G; Lowdell, M; Fielding, A; Samuel, E; Pang, K; Kottaridis, P; Morris, E;